A Multiscale In Silico Investigation of the Mechanics and Dynamics of Ex Vivo Coagulation by Cala, Megan P.
A Multiscale In Silico Investigation of the Mechanics
and Dynamics of Ex Vivo Coagulation
by
Megan Patricia Cala
Bachelor of Science in Biology, Seton Hill University, 2014
Submitted to the Graduate Faculty of
the Swanson School of Engineering in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy
University of Pittsburgh
2020
UNIVERSITY OF PITTSBURGH
SWANSON SCHOOL OF ENGINEERING
This dissertation was presented
by
Megan Patricia Cala
It was defended on
July 14, 2020
and approved by
Robert S. Parker, Ph.D., Professor, Department of Chemical and Petroleum Engineering,
Department of Bioengineering
Joseph J. McCarthy, Ph.D., Professor, Department of Chemical and Petroleum Engineering
Ipsita Banerjee, Ph.D., Associate Professor, Department of Chemical and Petroleum
Engineering, Department of Bioengineering
Jeffrey Vipperman, Ph.D., Professor, Department of Mechanical Engineering and Materials
Science, Department of Bioengineering
Dissertation Advisors: Robert S. Parker, Ph.D., Professor, Department of Chemical and
Petroleum Engineering, Department of Bioengineering,
Joseph J. McCarthy, Ph.D., Professor, Department of Chemical and Petroleum Engineering
ii
Copyright c© by Megan Patricia Cala
2020
iii
A Multiscale In Silico Investigation of the Mechanics and Dynamics of Ex
Vivo Coagulation
Megan Patricia Cala, PhD
University of Pittsburgh, 2020
Theories describing the coagulation cascade have been around for decades and have
greatly expanded in functional detail over the past several years. However, there still exists
a void in the literature on the quantification of the microscale contribution of individual
blood cell mechanics on the macroscale behavior of blood clots. This is due, in part, to the
fact that the trans-scale relationships between blood components are not fully understood. In
this work, we aim to bridge the gap between the known cell-scale phenomena of coagulation,
specifically platelet and fibrin interactions, and the measurable mechanics and dynamics of
whole blood clots.
The developed multiscale model consists of two main components: (1) a phenomenolog-
ical model of activated platelet adhesion and contraction and (2) a mechanistic model of
fibrin viscoelasticity and strain-hardening extensibility. The components of the multiscale
model include stand-alone discrete element method (DEM)-based cell-scale models for the
primary components of blood. The unique mechanical and dynamical behaviors observed
experimentally in single-platelet and single-fiber studies can be captured by this technique
due to the inclusion of phenomenological force models, namely piecewise linear functions
for the adhesion exhibited by activated platelets and Hill functions for the nonlinear elastic
modulus of fibrin.
The isolated platelet adhesion and fibrin extension models were developed and calibrated
separately before they were combined to study the emergent behavior of platelet and fibrin
assemblies. The platelet and fibrin compositions were varied between simulations to assess
the morphological and mechanistic differences of in silico-formed aggregates. Applying the
model within a dynamic framework was also used to obtain a macroscale metric of in silico
aggregate behavior that is comparable to one from existing clinical whole-blood diagnostic
devices like the thromboelastogram, or TEG. Specifically, we can quantify the platelet con-
iv
tribution to the strength of platelet and fibrin in silico aggregates. We observed a nonlinear
relationship between platelet concentration and platelet contribution that corroborates ex-
perimental studies. The culmination of the modeling efforts from this dissertation is a tool
that can be used and expanded to better understand the mechanistic detail of platelet and
fibrin contributions during coagulation.
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1.0 Introduction
Blood clotting, or coagulation, is an essential physiological mechanism that contributes
to homeostasis by stemming blood loss after vascular injury [1]. The complex, multi-step
mechanism of coagulation has been classically termed the “coagulation cascade,” and is
comprised of a sequence of several reactions involving blood cells, blood-cell fragments,
proteins, and other biological factors [41, 83]. Blood is comprised of red blood cells, white
blood cells, and platelets suspended in a protein-rich fluid called plasma [30]. Red blood cells,
present in the highest solids volume fraction, dominate blood rheology, but the concentrations
and interplay of other primary constituents, namely white blood cell fragments (platelets)
and proteinaceous meshes (fibrin), dictate the mechanics and dynamics of coagulation [78,
114]. At the onset of coagulation, platelets spontaneously activate and acquire adhesive
properties that facilitate platelet aggregation and the formation of a plug. The platelet plug
becomes the center of the clot, which is also stabilized by a fibrin mesh that polymerizes
throughout the clot.
The regulation of the coagulation cascade requires the harmonious interplay of several
key players and processes, including blood cell aggregation and adhesion, and the flow and
transport of important cells and clotting factors. It relies on the successful biochemical
communication of the entire network to maintain the spatiotemporal organization necessary
to resolve any imbalances within the system. Any minor disruption to any of these processes
or players can amplify to serious pathologies like hemorrhage or excess clotting.
Within the last century, remarkable progress has been made toward improving our under-
standing of coagulation and resolving the mechanical properties of blood clots [80, 33, 123].
The extent of hemostasis, the process by which bleeding is stopped, falls on a spectrum with
pathologies manifesting at both ends. Normal hemostasis consists of both the formation of
a clot and its subsequent breakdown after healing [107]. A perturbation to hemostasis can
lead to bleeding (hemorrhage) or to obstructive clotting (thrombosis). Hemorrhage results
from the delayed onset or altogether absence of clotting and/or the rapid occurrence of clot
lysis, whereas thrombosis results from excess blood clotting and/or the failure of clot lysis
1
[94]. The mechanical properties of blood can be related to hemostatic disorders and are
therefore commonly used in hematological disease diagnosis [95].
1.1 Mechanics and Dynamics of Hemostasis
Under physiological flow conditions, red blood cells have the most significant effect on
the mechanical properties of blood [108]. Round, biconcave, and extremely deformable, red
blood cells are able to squeeze through openings smaller than their 6-8 µm diameter. The
ability of the red blood cells to orient with the flow of blood leads to the non-Newtonian, shear
thinning nature of blood [54]. Specifically, under low shear conditions, blood is highly viscous,
and with increased shear, the viscosity of blood decreases nonlinearly as the red blood cells
deform and orient with the flow [93]. Platelets have a discoid shape that measures 2-3 µm
in diameter and 0.5 µm in height when circulating in their quiescent state [76]. They are
produced from fragmented bone marrow megakaryocytes and have important roles in immune
defense, cancer metastasis, and most relevantly, wound healing [113]. Due to their smaller
size and lower concentration than red blood cells, the effect of platelets on the mechanical
properties of blood under physiological flow conditions is negligible [30]. However, this reality
reverses nearly spontaneously at the onset of hemostasis.
The coagulation cascade begins when platelets are exposed to sub-endothelial collagen
or to high shear forces in the presence of clotting factors, which induces platelet activation.
Activated platelets secrete granules that modify their membrane surface characteristics, in-
ducing particularly adhesive properties and a more spherical structure [91]. Following platelet
activation, a platelet aggregate forms and becomes the center of the clot [24, 42, 43]. Upon
activation, platelet integrins, such as αIIbβ3, switch from low to high affinity states to facili-
tate platelet-fibrinogen interactions [27]. Fibrinogen is a fibrous macromolecule that bridges
platelets via αIIbβ3, allowing the formation of platelet aggregates [49].
At the same time, the activated platelets allow the conversion of endogenous prothrombin
into active thrombin, the enzyme necessary to induce the polymerization of fibrinogen into
fibrin bundles [106]. Thrombin also activates other nearby platelets. Fibrin monomers link
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together to form fibrin sub-units called protofibrils [32]. Protofibrils aggregate laterally and
wrap into fibrin fibers, which branch to make a three dimensional network [123]. Fibrin
serves to strengthen the clot by forming an extensible meshwork that is held together by the
adhesive platelets, where the degree of platelet activation dictates the strength of adhesion
and therefore ultimately the strength of the clot [98].
During clot formation, a process known as clot contraction occurs, in which the viscous
fluid plasma is displaced and much is expelled from the clot [81]. The volume of fluid plasma
expelled from a clot can be collected and measured as a surrogate for the extent of clot
contraction [109]. Although the function of red blood cells in clot contraction is not well
understood, their deformability is particularly noted because as clots contract, red blood cells
can deform through vessel structures smaller than their diameter [51, 60, 75]. Contracting
clots can also undergo subtle platelet and fibrin rearrangements. A shift in platelets and
fibrin to the exterior of the clot reduces the clot permeability and enhances would healing
[16].
The myriad of other cells and tissue components in the blood are capable of interacting
with a growing clot or thrombus and can contribute to its formation, but pale in comparison
to the role of platelets and fibrin [124]. Though the key coagulation contributors are known,
their particular mechanical influence is still only vaguely understood. The mechanical prop-
erties of clots and thrombi are critical to their physiological function and a determinant of
the response to treatment of both hemorrhagic and thrombotic conditions [123].
1.2 Measurements of Blood Mechanical Properties
1.2.1 Isolated cell-scale assessments
From a sample of whole blood, individual cell counts can be measured, such as platelet
count, red blood cell concentration (hematocrit), fibrinogen level, clotting times, and various
clotting factor levels, though these mere quantities do not reveal any insight into their
contribution to the mechanical properties of blood [37].
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With the invention of the atomic force microscope (AFM) in 1986, the study of how
underlying molecular mechanisms connect with macroscopic mechanical behaviors within
biological systems has gained momentum [123, 89]. Quantitative experimental measurements
of the physical properties of particles on the cell-scale can be performed with high resolution.
This technique has been applied to both platelets and fibrin, leading to greater insight into
their unique adhesive and extensible properties, respectively [25, 86].
By measuring the force required to rupture the bond between a platelet-platelet and
platelet-fibrin bond at varying degrees of platelet activation, the dynamics of platelets
throughout the stages of the coagulation cascade are better understood. Through two sem-
inal studies by Nguyen et al. and Lam et al., it was discovered that the adhesive power of
platelets increases with an increase in the degree of platelet activation [77, 56]. AFM has
been coupled with force spectroscopy to measure the extensibility of a single fibrin bundle.
Through a recent experimental study, it was reported that fibrin exhibits viscoelastic and
strain hardening properties, exhibited by nonlinear force versus strain profiles [63]. A single
strand of fibrin can be stretched up to 3.3 times its original length before rupturing.
1.2.2 Ex vivo whole-blood assays
In the clinic, the coagulation status of patients can be assessed using devices such as the
TEG, ROTEM, and hemodyne [78, 123]. These point-of-care devices have subtle differences,
but all evaluate the whole blood clotting process from platelet aggregation to fibrinolysis.
A TEG is the readout of a point-of-care device used in the clinic to obtain functional
coagulation state assessments with the simple addition of a sample of whole blood [96]. As
shown in Figure 1A, the device contains an initially stationary pin that is suspended in an
oscillating cup containing the blood sample. Changes in torque between the pin and the
cup resulting from clot formation are traced through a computer-processed signal of the pin
rotations. Parameter values from the TEG tracings are compared to reference ranges to
guide the treatment of potential coagulopathies [82]. A schematic of a sample TEG with the
labeled parameter values is shown in Figure 1B.
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Figure 1: Schematic of (A) a TEG cup containing a whole-blood sample and suspended pin hanging from a torsion wire and (B)
a normal TEG tracing (not to scale) resulting from an outline of the pin oscillations during coagulation with the five labeled
key parameters used to assess the coagulation state of its subject.
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The five key parameters characterizing a TEG tracing are the time to initiation of coag-
ulation (R), the rate of formation of the clot (α-angle), the maximal amplitude (MA) of the
oscillation, the time required for the oscillation to reach the maximal amplitude from the
start of clot formation (K ), and percentage decrease in amplitude at thirty minutes post-MA
(LY30 ). Traditionally, R depends on soluble clotting factors, K on surface active factors,
α on fibrinogen and platelets, MA on platelet count and functional clot strength, and LY30
on the degree of fibrinolysis [78, 9].
The dynamic parameters obtained from these tests are compared to standard ranges
obtained from a healthy control reference so that appropriate treatments or treatment cor-
rections can be designed and administered. Because MA represents contributions of various
blood components to the clot, including platelets and fibrin/fibrinogen, it is not the most
sensitive indicator of a platelet deficiency. Alternatively, the platelet component of clot
strength can be derived from the comparison of TEG tests performed with and without
platelet inhibition [98]. While the simple and straight-forward nature of the TEG is appeal-
ing to clinicians, the suggested treatments for coagulopathies are rarely precise, which often
leads to patients receiving a transfusional cocktail of blood-product therapies [9].
The dynamic capacity of the measurements made by these devices provides a distinct
advantage over static quantitative clinical tests [96, 82]. However, the meaningfulness of
the parameters measured by these devices is limited to the realm of the respective device
because the exact connection between the microscale in vivo mechanistic contributions of
whole blood constituents to the macro-observable parameters from these devices is not fully
understood.
1.3 Existing In Silico Models of Coagulation
Despite the vast advancements surrounding hemostasis and thrombosis over the past
three decades, bleeding complications are still the major immediate cause of morbidity and
mortality in the world [6]. To enhance the study of the complexities surrounding coagula-
tion, mathematical and computational modeling has been increasingly used in parallel with
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experimental studies [97]. Though simplifying assumptions and approximations are part
of every model, an improved understanding of coagulation physiology and more powerful
computing have led to the development of more accurate models in recent years.
Within the computational biomechanical framework, simulation objectives for hemato-
logical models typically guide the selection from continuum- and/or discrete-based methods
[115, 33, 2]. Continuum methods usually involve systems of coupled differential equations
whose solutions and applicability may be limited to a narrow scope of simulation condi-
tions and often represent oversimplified systems [30]. Alternatively, to bypass some of the
limitations and abstractions of continuum methods, more intuitive discrete methods can be
employed at the cost of increasing computational complexity [23, 117]. These methods ex-
plicitly define each particle as a specific type with distinct properties and laws that govern
the possible constituent interactions, enabling the fine control of heterogeneous systems. The
mechanical forces acting upon each particle are remembered and particle positions are reas-
signed at each time step [34]. Until the verge of instability is reached, decreasing the time
step of discrete models increases the model accuracy, but further increases the computational
cost.
There are several variations of discrete approaches, including adhesive dynamics (AD),
discrete element method (DEM), molecular dynamics (MD), smoothed particle hydrody-
namics (SPH), and dissipative particle dynamics (DPD) [122, 67, 38, 50, 26]. All of these
methods are grounded in the solution to Newtonian physics across a collection of particles.
Further coarse graining discretized systems can increase the utility in capturing emergent
behavior of complex collections of a large number of cells [33, 23, 117]. Several existing hema-
tological models have successfully captured the in vivo dual behavior of platelet margination
combined with the deformation of red blood cells in high shear scenarios [4, 85, 84]. The work
of Wang et al. has shown promise for capturing the interplay between a small number of cells
within a network or matrix, while accurately capturing the impact of fluid mechanical forces
from surrounding blood plasma [122]. The correlation between the dynamics of adhesion
and bond characteristics, such as association and elasticity, was an insightful advancement
made by Chang et al. in their model of platelets and white blood cells [12].
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A fluid dynamics technique known as Lattice Boltzmann Method (LBM) has been com-
bined with discrete particle-based methods to increase the accuracy of the solid-fluid inter-
action beyond that possible of continuum methods or discrete particle-based methods alone
[19, 64]. The fluid in a LBM framework is described with a distribution function defined as
the probability density of locating a given number of molecules with a certain velocity at
a certain place and time in the three-dimensional simulation frame [14]. The distribution
functions can propagate along neighboring nodes of the discretized simulation in a collision
and streaming fashion [11, 35].
Several groups have applied LBM to model the response of the vascular occlusion in
intracranial aneurysms to changes under various flow conditions [36, 40, 79, 132]. In sil-
ico models of ex vivo coagulation in three-dimensional space is an under-developed area of
computational hematological research, therefore motivating the work herein [8]. The multi-
scale and multiphase nature of blood motivates the use of a combinational model of a fluid
dynamics technique along with a discretized particle-based method [128, 129].
1.4 Relevant Computational Methods
A combinational method can capture the two-way phenomena of how the fluid dynamics
are influenced by the presence of particles, and how the displacement of the particles is
driven by the fluid-induced forces [28]. In our framework, solid-fluid coupling is computed
at each time step by first obtaining the fluid solution with LBM, and then updating the
particle positions using DEM. From the resulting increase in resolution of the fluid flow and
increase in accuracy of the force calculations at the solid-fluid boundary, a unique insight
into the interplay between biophysics and the details of blood is expected [22, 59].
1.4.1 Discrete Element Method (DEM)
In DEM, the bulk evolution of particle assemblies is calculated through the integration
of the forces of interacting particle pairs [21, 130]. The solution to Newton’s equations of
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motion are used to calculate the particle trajectories. Equations 1.1 and 1.2 describe the
linear and angular particle motion, respectively,
mp
d~vp
dt
= −mp~g + ~Fn + ~Ft (1.1)
Ip
d~ωp
dt
= ~R× ~Ft (1.2)
where mp, ~vp, ~g, Ip, and ~ωp are the mass, translational velocity, gravity vector, moment of
inertia, and rotational velocity of particle p. ~Fn and ~Ft are the normal and the tangential
forces, respectively, and ~R is the vector between the center of particle p and the contact
point where ~Ft is applied.
Several force-displacement models have been developed based on theoretical contact me-
chanics [20]. The accuracy of calculations depends on the contact models selected. The
work herein follows the theory developed by Hertz [47]. The normal component of a collision
between two particles is chosen according to the elastic properties of the solids. Considering
pairwise interactions among particles, the normal force, assumed to be elastic during the
initial stages of loading, is described by Equation 1.3,
F en = k
e
nα
3/2 (1.3)
where α is the amount of particle-particle overlap or particle deformation and can be calcu-
lated from Equation 1.4,
αi = (Ri +Rj)− δij (1.4)
where Ri and Rj are the undeformed radii of particles i and j, respectively, and δij is the
distance between the two geometric centers of each particle. The elastic normal contact
stiffness, ken, can be related to the particles’ mechanical properties, including their Young’s
moduli (E) and Poisson’s ratios (v), according to Equation 1.5,
ken =
4
3
E∗
√
R∗ (1.5)
where E∗ and R∗ are
1
E∗
=
1− v2i
Ei
+
1− v2j
Ej
(1.6)
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1R∗
=
1
Ri
+
1
Rj
(1.7)
respectively [47].
The tangential force model used for the work herein was derived by Walton and Braun
[119]. For each time-step, the new tangential force, Ft, acting at the interparticle contact
point is defined as Equation 1.8
Ft = Ft,old − kt∆s (1.8)
where Ft,old is the tangential force from the previous time-step and kt∆s is the incremental
change in the tangential force during the present time-step due to relative particle motion
[118]. In other words, ∆s is the relative surface displacement between the contacting particles
during the current time-step and can be calculated from the component of the velocity that
is tangent to the contact surface, vt (i.e. ∆s = vtdt, where dt is the time-step). The frictional
stiffness, kt, is defined as Equation 1.9
kt = 8G
∗a (1.9)
where G∗ is the effective shear modulus defined as Equation 1.10 and a is the contact radius.
1
G∗
=
2− vi
Gi
+
2− vj
Gj
(1.10)
1.4.2 Lattice Boltzmann Method (LBM)
LBM is a class of computational fluid dynamics methods used to simulate fluid flows with-
out directly solving the equations of continuum fluid mechanics [3, 65, 101]. It is based on
the microscopic particle models and mesoscopic kinetic equations and assumes that macro-
scopic behavior of a fluid system is not very sensitive to the underlying microscopic particle
behavior if only collective macroscopic flow behavior is of interest [99]. The fundamental
idea of LBM is to incorporate the essential physics of the micrscopic process in a mescopic
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kinetic model so that the relationship among average properties at the macroscale conforms
to the Navier-Stokes equations. In the theoretical studies and simulations of LBM, various
lattice discretization schemes have been proposed in one, two, and three dimensions. The
standard nomenclature used to classify the different schemes is DiQj, where i represents the
number of dimensions (1D, 2D, or 3D) and j represents the number of discrete directions (3
for 1D, 6 or 9 for 2D, and 15, 19, or 27 for 3D) [3]. D3Q19, 3D with 19 discrete velocities,
has been shown to provide a suitable combination of computational stability and accuracy,
thus the chosen scheme for this work. A schematic of the D3Q19 lattice velocities is shown
in Figure 2.
The governing equation for the evolution of the LBM fluid distribution functions is
defined as Equation 1.11
fi(x+ eiδt, t+ δt)− fi(x, t) = fi(x, t) + Ωi(x, t) (1.11)
where Ωi(x, t) is the collision operator. The most widely implemented LBM model, which
utilizes the Bhatnagar-Gross-Krook (BGK) approximation for the collision operator, was
chosen for the work herein [5, 87]. The evolution of the fluid can be calculated from a
modified Equation 1.11, included as Equation 1.12, which contains two sub-steps that are
executed during each computational iteration: streaming and collision.
fi(x+ eiδt, t+ δt)− fi(x, t) = −1
τ
[fi(x, t)− f eqi (x, t)] (1.12)
In the governing equation, fi, x, t, ei, and δt are the probability distribution function (PDF)
of a node in direction i, position, time, microscopic velocity, and time step, respectively [7].
The left-hand-side of Equation 1.12 represents the streaming step, in which fluid particles are
propagated across the lattice. The right-hand-side of Equation 1.12 is the collision operator,
where τ is the dimensionless relaxation time that controls the rate that fi approaches f
eq
i ,
the equilibrium probability distribution function (EDF). The EDF can be related to the fluid
density (ρ), the fluid velocity vector (~u), a weighting factor (wi), and the lattice speed (c)
according to Equation 1.13.
f eqi (x, t) = wiρ
[
1 + 3
~e · ~u
c2
+
9
2
(~e · ~u)2
c4
− 3
2
~u · ~u
c2
]
(1.13)
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c13
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c12
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c15
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c7
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Figure 2: The 19 lattice velocities (~ci) used in the D3Q19 discretization scheme of LBM.
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When the D3Q19 lattice discretization scheme is used, 19 discrete particle velocities in
directions ~ei are introduced and defined according to Equation 1.14.
~ei =

e0 = c(0, 0, 0)
e1 = c(0, 1, 0)
e2 = c(0,−1, 0)
e3 = c(0, 0, 1)
e4 = c(0, 0,−1)
e5 = c(1, 0, 0)
e6 = c(−1, 0, 0)
e7 = c(0, 1, 1)
e8 = c(0,−1,−1)
e9 = c(0, 1,−1)
e10 = c(0,−1, 1)
e11 = c(1, 0, 1)
e12 = c(−1, 0,−1)
e13 = c(−1, 0, 1)
e14 = c(1, 0,−1)
e15 = c(1, 1, 0)
e16 = c(−1,−1, 0)
e17 = c(−1, 1, 0)
e18 = c(1,−1, 0)

(1.14)
The density (ρ) and velocity vector (~u) are related to the PDF and EDF according to
Equations 1.15 and 1.16.
ρ =
∑
i
fi =
∑
i
f eqi (1.15)
ρ~u =
∑
i
~eifi =
∑
i
~eif
eq
i (1.16)
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The pressure (p) is calculated directly from the equation of state of an ideal gas according
to Equation 1.17,
p = c2sρ (1.17)
where cs is the speed of sound, related to the lattice speed (c), given by cs = c/
√
3.
In the GBK model, viscosity (ν) is defined as Equation 1.18.
ν = c2s(τ −
1
2
)δt (1.18)
The bounce-back rule applies for nodes designated as solid to reflect the fluid in the
opposite direction at the collision stage. If boundaries are set to be periodic in a particular
direction, the last face of nodes is contiguous with the opposing face to ensure the lattice is
closed in the periodic direction [3].
1.5 Dissertation Overview
This dissertation outlines the development, validation, and application of a multiscale
discrete element method (DEM)-based in silico model of platelet and fibrin interactions
during ex vivo blood coagulation. Chapter 2 focuses on the development of a model that
captures the mechanics and dynamics of activated platelets, namely platelet-platelet, and
platelet-fibrin interactions. Parallel to Chapter 2, the focus of Chapter 3 is the development
of a mechanistic model that captures the viscoelastic and strain-hardening behavior of fibrin,
the polymer that forms an integrated meshwork throughout a growing clot. Chapter 4
combines the platelet model from Chapter 2 and the fibrin model from Chapter 3 with
a fluid dynamics technique called the Lattice Boltzmann Method (LBM) to evaluate the
emergent behavior of pre-assembled clots with varied concentrations of activated platelets in
the presence of both implicitly and explicity modeled fibrin bundles. Chapter 5 applies the
multiscale model from Chapter 4 to a dynamic framework to measure the physical strength of
the platelet-fibrin networks upon exposure to a linear stretching force. The resulting dynamic
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multiscale model provides the underlying framework for a tool that can be used to understand
the in vitro microscale contribution of fibrin and platelets on the macro-observables of whole
blood point-of-care devices.
The focus of Chapter 2 is the development of a phenomenological model of activated
platelet adhesion. Though far less numerous than red blood cells in the circulatory system,
platelets play a critical role in coagulation [73, 92]. As the first responders to a bleeding
or thrombotic event, platelets form small aggregate plugs that become the center of the
clot [55]. Platelets are also active recruiters of downstream procoagulant activity, including
the activation of nearby platelets and clotting factors [4]. We seek to capture the adhesive
characteristics of platelets in silico by including two distinguishable forces that act between
a platelet and its adherent substrate. The adhesive force resists platelet separation and the
contractive force induces particle-particle overlap at the equilibrium position of a platelet
and its neighbor. Three levels of platelet activation can be modeled, whereby the adhesive
capacity increases with each level of activation. Chapter 2 functions as a cell-scale build-
ing block of the multiscale model established in Chapters 4 and 5. Model validation is
performed with the availability of rupture force-strain information obtained from in vitro
isolated platelet-platelet and platelet-fibrin interaction studies.
Chapter 3 covers the development of a mechanistic model of fibrin viscoelasticity and
strain-hardening extensibility. Fibrin strands assemble during the early stages of the coag-
ulation cascade to form the fibrinous networks that extend throughout clots and maintain
clot integrity in vivo under high arterial pressure [10, 111, 112]. Several distinct mechanical
properties of individual fibrin strands, including viscoelasticity and strain-hardening exten-
sibility, facilitate the physiological functionality of these polymers [17, 100]. From in vitro
extension-retraction studies of single fibrin bundles, the distinct mechanical properties can
be quantified and used to validate our model. Specifically, the degree of strain-hardening is
observed by a comparison of the increased slope at increased strain to the initial slope on
the stress-strain curves [63]. The viscoelastic behavior is evident by the hysteresis, or the
departure between the extension and retraction curves, where the area between the curves is
proportional to the energy dissipated [57, 95]. In silico, we can model both of these mechan-
ical properties of fibrin by mathematically defining the elastic modulus as a Hill function.
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Since fibrin becomes more viscous with increased strain, the parameters of the Hill function
that correspond to the retraction portion of the stress-strain curves are modified as the strain
increases [68]. The Hill function parameters for the extension and retraction curves are all fit
to experimental data. Similar to Chapter 2, Chapter 3 also functions as a cell-scale building
block of the multiscale model proposed in Chapters 4 and 5.
In Chapter 4, a platelet and fibrin combination model is developed and validated with in
vitro clot properties. By combining the two cell-scale models of platelets and fibrin, described
in Chapters 2 and 3, respectively, with a fluid dynamics technique called Lattice Boltzmann
Method (LBM), we take the first steps toward a multiscale model of coagulation. From
simulations of the combined model, we demonstrate that variations in blood composition of
key blood components leads to different qualitative and quantitative descriptors, similar to
the observables in permeability and contractility in vitro experiments [126, 108]. A patho-
logical fibrin scenario is simulated by incorporating fibrin as implicit entities to investigate
the effect of compromised fibrin on aggregation. With our validated model, we define rela-
tionships between the concentrations of blood coagulation contributors and corresponding
clot permeabilities and pore size distributions.
Chapter 5 extends the static model of ex vivo platelet and fibrin assemblies from Chapter
4 to a dynamic framework by applying a uni-axial stretch to the aggregates. By simulating
ex vivo clot dynamics, we avoid multiple degrees of complexity associated with coagulation
in vivo revolving around the modular flow conditions during bleeding and thrombotic events
as well as the myriad of biophysical and biochemical signals and cues that stem from the
exposure of the damaged sub-endothelial matrix [41, 24]. From the simulations of stretching
aggregates, we generate an in silico aggregate metric, specifically the platelet contribution,
that is comparable to one from existing clinical whole-blood diagnostic devices like the TEG.
The culmination of the modeling efforts within this chapter is a tool that can be used and
expanded to better understand the mechanistic detail of platelet and fibrin contributions
during coagulation.
The key contributions of this dissertation include the following:
• a calibrated DEM-based model of platelet adhesion with the capacity to vary platelet
activation
16
• progress toward traversing the gap to the macroscale with a platelet aggregate formation
model
• development of methods to quantify the emergent aggregate morphologies, i.e. pore size
distribution
• two approaches of fibrin inclusion, i.e. immobile lines and flexible strands of tethered
particles
• application of LBM to quantify the platelet and fibrin aggregate permeabilities
• application of the platelet and fibrin aggregates to a dynamic framework to quantify their
strength
• development of a method to quantify the platelet contribution to the aggregate strength
17
2.0 Phenomenological Model of Activated Platelet Adhesion
2.1 Background
The focus of Chapter 2 is the development of a stand-alone, DEM-based model of acti-
vated platelets that accurately captures the mechanics of platelet-platelet and platelet-fibrin
interactions. Platelets are the first responders to an induction of hemostasis, such as vascular
injury. In the bloodstream, platelets interact with hundreds of biochemical and biophysical
signals, including fibrin networks [31]. Platelets can sense certain aspects of their mechanical
microenvironments, such as substrate stiffness, and respond by releasing dense granules and
undergoing membrane surface conformational changes [88]. The dense granules can activate
nearby platelets and the membrane surface conformational changes can expose the GPI-
IbIIIa integrin complex, the platelet-fibrin mediator [77]. The exposure to stiff substrates
increases platelet activation, and therefore platelet adhesion and contraction [61]. The abil-
ity of platelets to sense microenvironments in the bloodstream and decipher the biochemical
and biophysical signals into stages of platelet activation provides a possible physiological
explanation of the heterogeneity of clots and thrombi during the coagulation cascade [88].
Since platelets are the building blocks of clots and thrombi, accurately capturing platelet
interaction mechanics and dynamics is critical to building a meaningful multiscale model of
coagulation. A computational model developed by Mori et al. combined a Stokesian fluid
dynamics technique with a viscoelastic model to capture the role that implicitly-modeled fib-
rin plays in explicitly-modeled platelet-platelet aggregation within in a simple shear scenario
[74]. Again in simple shear-flow, Mody et al. performed a series of studies using Platelet
Adhesive Dynamics (PAD) to model the traction forces associated with platelet adhesion to
an exposed injured vessel wall [69, 71, 70, 72].
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We develop a model to capture the primary adhesive role that platelets have in hemosta-
sis. We simulate platelet mechanics in an ex vivo environment, i.e. in the absence of flow
and surrounding vasculature, with the explicit inclusion of both platelets and fibrin as a
means to capture the interplay of platelet-platelet and platelet-fibrin interactions at a higher
resolution than existing models.
2.2 Model Development
The DEM-based model of activated platelets captures the mechanics of platelet-platelet
and platelet-fibrin adhesion by accounting for the forces from biochemical bonds associated
with coagulation, in addition to the frictional and normal forces that are classically considered
in execution of this method. Platelets are treated as the explicit discrete elements. The forces
acting on a given platelet, i, are calculated according to Equation 2.1, which is modified
from Equation 2.1 to include ~Fs, a calibrated adhesive spring force that is unique to this
implementation of DEM.
mi
d~vi
dt
=
∑
(~Fn + ~Ft + ~Fs) (2.1)
Similar to Equation 2.1, m is the particle mass, ~v is the particle velocity, and ~Fn and ~Ft
are the normal and tangential body forces, respectively. In this work, the non-adhesive
interparticle contacts are modeled using the dampened JKR model for Hertzian contact
mechanics [103]. The radius of the contact spot, a, can be expressed as
a =
3
√
3R∗Fn
4E∗
(2.2)
where R∗ is the effective particle radius and E∗ is the effective Young’s modulus. The
decrease in the normal contact force due to damping is proportional to the product of the
normal velocity and the overlap distance of particles in contact. Rotational phenomena
is assumed to be small in the presence of adhesion and although the precise modeling of
platelet deformation is not considered, a good approximation of the mechanical behavior is
still possible.
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Platelet membrane surface receptors give rise to the strong adhesive properties of acti-
vated platelets that enable the platelet-substrate connections [13]. To capture this adhesive
property of platelets in silico, we simulate platelets as single particles with implicit springs
that represent mediators and membrane receptors. The variable lengths of the mediators
are modeled by defining concentric spheres about the in silico platelets, whereby the me-
diator lengths are equal to the radial difference between an outer sphere and the surface
of the platelet. Figure 3 shows a schematic of the various mediator lengths defined by the
concentric spheres surrounding a platelet.
2.2.1 Rupture Forces
We used the force-distance curves obtained from an AFM experimental investigation of
platelet-platelet bond rupture as the basis for the mediator lengths and adhesive contribu-
tions [77]. We used a similar experimental study to obtain the platelet-fibrin rupture infor-
mation to calibrate our model [56]. A schematic of the experimental study used to calibrate
the platelet-fibrin interactions within our model is included as Figure 4. To calibrate the
platelet-platelet interactions, the fibrin-coated surfaces seen in Figure 4 were replaced with
platelet-activating materials and two platelets were positioned within the plates, allowing
the platelet-platelet rupture force to be measured. Upon initialization of the experiment, the
platelet attached to the top plate was placed in contact with either the fibrin-coated surface
or another platelet before the bottom plate was lowered at a constant velocity until the top
platelet became detached. The point of detachment was determined by a clear separation
between either the top platelet and the fibrin-coated surface or the two platelets.
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Figure 3: Schematic of a simulated platelet with the four mediator lengths defined by concen-
tric spheres of increasing diameter with Roman numeral labels at the edges of the mediator
lengths that correspond to the endpoints of Equation 2.3. The mediator lengths are defined
by the distance between the platelet surface and the outer edge of the concentric spheres.
Note that the depicted mediator lengths represent a general case and are therefore not to
scale.
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Figure 4: Schematic of the AFM experiment used to measure the resistance force of platelet-
platelet and platelet-fibrin adhesive interactions. An activated platelet is placed in contact
with either a fibrin-coated surface or another activated platelet and the force required to
separate the plates is tracked as the upper plate remains stationary and the lower plate
moves in the vertical direction away from the upper plate at a constant velocity. The curve
represents the measured force as a function of the separation distance. The colored phases
of the force-distance diagram correspond to the ruptured platelet mediators aligned with
Figure 3. This figure was adapted from [56].
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To implement the different adhesive behaviors, i.e. platelet-platelet and platelet-fibrin,
we introduce an implicit spring between a platelet and an adherent substrate, such as fib-
rin or another platelet. Prior to initializing a simulation, the particle types are designated
as either platelet particles or fibrin particles so that the pairwise adhesive interaction is
classified correctly as either platelet-platelet or platelet-fibrin. Fibrin-fibrin interactions are
handled as described in Chapter 3. The spring forces for each type of adhesive interaction
are mathematically defined by continuous piecewise linear functions, where the interval end-
points correspond to the lengths of the mediators. The piecewise linear function for activated
platelet interactions is defined as
~Fs(x) =

mIx+ bI, 0 ≤ x ≤ I
mIIx+ bII, I < x ≤ II
mIIIx+ bIII, II < x ≤ III
mIVx+ bIV, III < x ≤ IV
(2.3)
where mI-IV and bI-IV are the slopes and intercepts, respectively, of the corresponding
mediator lengths, x is the distance between a platelet particle surface and another adherent
surface, and I-IV are the endpoints of the concentric adhesive annuli and/or the platelet
mediator lengths. In practice, ~Fs functions to resist the separation between two particles,
either two platelets or a platelet and fibrin particle, only after their surfaces have overlapped
or the distance between their centers meets a defined adhesive criteria as discussed in Chapter
2.2.2.
2.2.2 Adhesive Loading
Platelet surfaces are coated with filopodial extensions that function to grab nearby
platelets or other adhesive surfaces in order to facilitate platelet aggregation [52]. The
actomyosin-based contraction mechanics and dynamics of platelets are known to influence
the mechanical properties of clots and thrombi by shrinking, stiffening, and rearranging [56].
To gain insight into the mechanism of platelet contraction, single-platelet measurements
taken at the point of platelet activation, when the first platelet contractions are possible, are
particularly useful [48]. In order to simulate the effects of the platelet filopodial extensions
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in silico, we incorporated a capture radius about the platelets. The capture radius is defined
as the length of the first mediator, which ranges from 1.9 to 3.1 µm. The adhesive loading
force is assumed to be elastic and follows Equation 2.3.
We extended our model to perform platelet contraction, which was observed in an ex-
perimental study performed by Lam et al. The study reported the spontaneous platelet
activation and contraction of unactivated platelets in the presence of fibrin [56]. In order
to capture a desired rate of platelet contraction, we tuned the viscous contribution of the
repulsive normal force, Fn, to balance the constant attractive spring force, Fs, which are
related by Equation 2.1. Increasing the viscous contribution of Fn, dampens the oscillations
that arise from the strong contraction force and the opposing normal force. After validating
the platelet-contraction portion, our platelet model captures the mechanics and dynamics of
platelet-platelet and platelet-fibrin interactions resulting from the adhesive and contractive
power of platelets as shown in Figure 5A. In Figure 5A, a positive force corresponds to an
attractive force between interacting particles and a negative force corresponds to a repulsive
force. We adjusted the equilibrium position of an adhesive particle pair to account for their
soft and flexible nature that results in a small platelet-platelet or platelet-fibrin overlap at
equilibrium. The equilibrium spring length or distance between adherent particle centers
is less than the diameter of a particle, resulting in particle-particle overlap at equilibrium
shown schematically in Figure 5B. Additionally, the spring force governing contraction is
zero until a platelet or fibrin particle enters another platelet’s contact radius.
2.3 Simulation Results of Rupture Force Studies
2.3.1 Platelet-Fibrin and Platelet-Platelet Adhesion
To capture platelet-fibrin and platelet-platelet adhesion in silico, the parameters corre-
sponding to the slopes, intercepts, and endpoints included in Equation 2.3 are fit to the
corresponding curves in Figure 6. The fitted parameter values are listed in Table 1. The
resulting piecewise linear curves of platelet-fibrin and platelet-platelet adhesive rupture me-
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Figure 5: (A) Simulated contact force calculated by the difference between the normal
repulsive force and the contraction force between a simulated platelet and a non-platelet
particle plotted against the distance between the 2 µm particle centers and (B) the simulation
visualization of the equilibrium position between a contracted platelet (black) and a non-
platelet particle (green), demonstrating the particle overlap at equilibrium.
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Table 1: Parameter values from Equation 2.3 used to fit curves in Figure 6.
Parameters I II III IV mI mII mIII mIV bI bII bIII bIV
(Units) (µm) (nN/µm) (nN)
Platelet-fibrin 3.1 4.5 5.0 11.0 -22.2 24.6 38.1 0.01 -20.0 -167.5 -227.0 -64.5
Platelet-platelet 1.9 2.2 5.8 6.1 -1.5 2.6 -0.1 1.5 0.0 -9.0 -1.2 -18.0
chanics are included as the colored dashed lines in Figure 6a and 6b, respectively. The colors
of the dashed lines correspond to the colored platelet mediators that are depicted in Figure
3.
An observation of the digitized data included in Figure 6a of the platelet-fibrin rupture
forces and Figure 6 of the platelet-platelet rupture forces, from Lam et al. and Nguyen et
al. respectively, reveals that platelet-fibrin bonds are nearly thirty times stronger than the
strongest platelet-platelet bonds [56, 77]. A platelet’s maximum rupture force is governed
by the shortest (red) mediator and the rupture force measured at the greatest distance is
the spring force associated with the longest (blue) mediator before complete separation or
rupture. The in silico reproduction of the rupture force-distance curves of platelet-fibrin
and platelet-platelet adhesion demonstrates that our model is able to phenomenologically
capture the mechanics of platelet adhesive interactions as shown in Figure 6.
2.3.2 Platelet-Platelet Subject to Varied Activation
To capture varied platelet activation in silico, we implement the same implicit spring
between platelet-platelet interactions, but fit the parameters corresponding to Equation 2.3
using experimental force-distance curves obtained by Nguyen et al. in a study of platelet-
platelet bond rupture at various degrees of platelet activation. To induce different degrees of
activation experimentally, platelets were exposed to glass surfaces passivated with collagen,
fibronectin, and poly-L-lysine. The same AFM technique depicted in Figure 4 was performed
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Figure 6: Simulated (– –) and experimental [56, 77] (—) rupture force of platelet-fibrin (a)
and platelet-platelet (b) adhesion versus separation distance. The colors of the dashed lines
correspond to the colored platelet mediators depicted in Figure 3.
Table 2: Parameter values from Equation 2.3 used to fit curves in Figure 7.
Parameters I II III IV mI mII mIII mIV bI bII bIII bIV
(Units) (µm) (nN/µm) (nN)
Non-/weakly-activated 1.3 1.6 2.3 4.2 -1.3 0.0 2.3 -4.4 -0.7 0.3 0.7 -2.9
Partially-activated 1.8 2.4 5.0 5.4 -1.2 0.0 2.6 -6.5 -0.3 0.2 3.1 16.9
Activated 1.9 2.2 5.8 6.1 -1.5 2.6 -0.1 1.5 0.0 -9.0 -1.2 -18.0
using the aformentioned passivated glass surfaces in place of fibrin-coated surfaces. We used
the experimental force-distance curves obtained in that study to define three distinct de-
grees of activation, namely non-/weakly-activated, partially-activated, and activated, which
correspond to the respective passivated glass surfaces.
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The fitted parameter values from Equation 2.3 that correspond to the different degrees
of activation are listed in Table 2. The simulation results of the rupture force between
two activated platelets at the three degrees of activation are included as the dashed curves
in Figure 7. The degree of activation increases in the subplots from left to right. From
both experimental and simulation results in Figure 7, it is clear that the strongest platelet
adhesive bonds are governed by the platelets activated to the highest degree signified by
the curve with the greatest force magnitude on the y axis. Additionally, the initial capture
radius and the maximum range of the adhesive interactions increases with each degree of
activation. The initial capture radius corresponds with the length of the shortest mediator,
as explained in Chapter 2.2.2, is located at the global minimuma of the curves in each
subplot of Figure 7. The maximum range of the adhesive interactions, which occurs just
before the platelet-platelet bonds completely rupture, corresponds to the point with the
greatest distance on the curves in Figure 7. The rupture force curve that corresponds to
the activated platelet scenario in Figure 7 is initial platelet-platelet interaction presented in
Figure 6. The in silico reproduction of the rupture force-distance curves of platelet-platelet
adhesion demonstrates that our model is able to phenomenologically capture the mechanics
of varied platelet activation.
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The simulation results of platelet-platelet and platelet-fibrin rupture forces are included in
Figures 4 and 5, respectively.
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Figure 4: Simulated and experimental rupture forces of platelet-platelet interactions between a
non-/weakly activated platelet and (A) a non-weakly activated platelet, (B) a partially-activated
platelet, and (C) an activated platelet, plotted against the distance between the two adhering
platelet surfaces. Experimental data was digitized from [43].
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Figure 5: Simulated and experimental rupture force of a platelet-fibrin interaction plotted against
the distance between the platelet and the fibrin outer edges. Experimental data was digitized
from [44].
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Figure 7: Simul d and experimental rupture forces of pla let-platelet interactions a non-/weakly activated platelet
and (A) a non-weakly activated platelet, (B) a partially-activated platelet, and (C) an activated platelet, plotted against the
distance between the two adhering platelet surfaces. Experimental data was digitized from [77].
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2.4 Summary
In total, we can implement four levels of platelet activation ranging from inactive (no
adhesion) to fully-active (strongest adhesion) that governs platelet-platelet interactions. To
do so in silico, we introduce a spring force between interacting active platelets. The spring
forces for each activation level are mathematically defined by piecewise linear functions,
where the Roman numerals or piecewise linear endpoints correspond to the lengths of the
mediators. If platelets with dissimilar activation degrees are interacting, the spring force
resulting from their interaction corresponds to the piecewise function of the platelet activated
at the highest level. Platelet and fibrin interactions can also be modeled in the same manner
as platelet-platelet interactions by incorporating a unique piecewise linear description that
is calibrated to experimental data from the literature. The spring force that describes the
aforementioned platelet adhesive interactions follows Equation 2.3, where x is the distance
between a platelet particle surface and either another platelet particle or fibrin. The fitted
parameter values that correspond to Equation 2.3 can be found in Table 2 for platelet-platelet
interactions of the various activation levels and Table 1 for platelet-fibrin interactions.
A platelet’s maximum possible rupture force, which is governed by the shortest mediators,
increases with the level of activation [77]. The rupture force measured at the largest distance
is the spring force associated with the longest mediator between a platelet and its adherent
substrate before complete separation. An observation of the digitized data included in Figure
7 of the platelet-platelet rupture forces and Figure 6 of the platelet-fibrin rupture forces, from
[77] and [56] respectively, reveals that platelet-fibrin bonds are nearly thirty times stronger
than the maximum platelet-platelet bonds. The level of platelet activation, dictated by its
mechanical microenvironment, is the likely determinant of the quantity of granules released
and the extent of membrane-surface change, which in turn, could manifest in the variations
observed in the rupture force dynamics [77]. The in silico reproduction of the rupture
force-distance curves corresponding to various levels of platelet activation demonstrates that
our model is able to broadly capture the mechanics and dynamics of platelet-platelet and
platelet-fibrin interactions.
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Our model assumes that all mediators within a given concentric circle shown in Figure
3 rupture and reform simultaneously, thus resulting in the reduced noise compared to the
experimental counterpart. A consequence of the simplifying assumption is the absence of
the mechanistic detail of platelet-platelet and platelet fibrin interactions. In order to expand
the mechanistic accuracy and therefore the goodness of fit of our model to the experimental
data, the structure of the single mediator per concentric circle would need to include multiple
mediators whose lengths and connectivity vary with a certain degree of stochasticity for each
colored concentric circle. With the aim of utilizing the developed cell-scale model as the
foundation of a larger, multiscale model, the taken phenomenological approach satisfies the
computational feasibility concerns that arise during scale-up of highly mechanistic cell-scale
counterparts. The phenomenological cell-scale model of platelet-platelet and platelet-fibrin
adhesion presented herein is essential to capturing the micro-mechanical contributions in
a multiscale model of coagulation. This model serves as the foundation to examine the
collective behavior of platelet and fibrin aggregates that is discussed in subsequent chapters
of this dissertation.
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3.0 Mechanistic Model of Fibrin Viscoelasticity and Strain-Hardening
Extensibility
3.1 Background
Fibrin is a polymer that forms when activated thrombin exceeds a threshold concentra-
tion in the presence of endogenous fibrinogen [45]. Fibrin strands assemble during the early
stages of the coagulation cascade to form the fibrinous network that spreads throughout a
clot and helps to maintain clot integrity in vivo under high arterial pressure [112]. Further
stabilization can occur through the addition of covalently bonded crosslinks between adja-
cent fibrin monomers [63]. The formation of fibrin networks contributes to the cessation of
bleeding by coupling and contracting nearby platelets to generate a gel-like assembly. The
unique mechanical properties of individual fibrin strands, including viscoelasticity and strain-
hardening extensibility, facilitate the physiological functionality of these polymers [18, 100].
At the microscale, changes in protein folding and cross-linking can alter downstream fibrin
formation and function. At the macroscale or whole-blood level, fibrin stretching and align-
ment are responsible for changes in blood clot mechanical properties and can be related to
disorders and disease [95]. An understanding of the contribution of single fibrin fibers on the
whole-blood mechanics is critical for an accurate multiscale model of clot behavior.
Unlike fully elastic solids that deform proportionally under stress and independently of
the rate of strain, the deformation of viscous materials, like fibrin, behaves in a way that
stress is proportional to the rate of strain but not necessarily proportional to the strain itself
[46]. The fractional elastic and viscous components of fibrin will determine the response of a
clot or thrombus to an applied external force [53]. Stiff clots and thrombi are able to resist
deformation and those with a greater viscous component will return to their original shape
more slowly, if at all, once the external force is released [123]. The most widely accepted
theory to describe the physiological source of the viscoelastic behavior is the presence of
distinct domains within the bundle that expand and contract with dissimilar dynamics [63].
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The objective of Chapter 3 is to develop an in silico model using Discrete Element
Method (DEM) that captures the extensible, strain-hardening, and viscoelastic behavior of
individual fibrin bundles. Similar to 2, this chapter also functions as a cell-scale building
block of the multiscale model elaborated upon in subsequent chapters.
3.2 Model Development
3.2.1 Fibrin as Springs in Series
Fibrin bundles can exceed a 330% strain before rupturing, though the fibrin integrity
is threatened when the elastic limit of the bundle is exceeded, which occurs prior to the
point of rupture [63]. In silico, we can capture the highly extensible nature of fibrin by
modeling fibrin as a chain of adjacent solid spheres or particles connected in series via implicit
mechanical springs. The equilibrium spring length (distance between particle centers) is less
than the diameter of a particle, resulting in substantial particle overlap at equilibrium. The
purpose of the overlapping particles at equilibrium or prior to an extension event is to
mitigates physical gaps between adjacent particles at full extension. Aside from the implicit
spring interaction between adjacent fibrin particles within a given strand, fibrin particles do
not physically interact. Avoiding or ignoring intra-strand fibrin interactions is particularly
important because the substantial overlap forced upon adjacent fibrin particles violates the
laws of physics and therefore could not be carried out with DEM.
An atomic force microscopy (AFM) experimental investigation was performed by Liu
et al. and used to guide the calibration of the in silico fibrin particles and strand length
[63]. Fibrin particles were assigned a diameter of 0.2 µm, or ten times smaller than the
in silico platelet particles. The AFM stage from extension study had a width of 12 µm,
which corresponds to 59 in silico particles when the particles have an initial overlap of two
thirds with respect to their diameter. A schematic of a single fibrin bundle at equilibrium is
included as Figure 8A.
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We can execute an extension-retraction case study on a single in silico fibrin strand
by freezing the end-point fibrin particles and forcing the center particle to have a specific
positive velocity in the vertical direction, followed by the same velocity in the negative
vertical direction until the strain of the entire strand returns to zero. Five snapshots of a
visualization of the extension portion of this in silico case study are compiled as Figure 8,
showing the progression from 0-225% strain.
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Figure 8: Simulation visualization of (A) the unstretched equilibrium stage of a fibrin strand composed of overlapping particles
tethered together by an attractive force between adjacent particles and three intermediate snapshots (B-D) of the progression
to 225% strain (E).
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3.2.2 Hooke’s Law and Hill functions
To capture the strain-hardening and viscoelasticity of the in silico fibrin strand, we
can mathematically describe the implicit spring that tethers adjacent fibrin particles as a
Hookean spring with an elastic modulus of Hill functional form. Since fibrin becomes more
viscous with increased strain, the parameters of the Hill function that correspond to the
retraction portion of the stress-strain curves are modified as the strain increases [68]. The Hill
function parameters for the extension and retraction curves are mapped to experimentally
generated data.
We used the force-strain curves obtained from an AFM experimental investigation per-
formed by Liu et al. as the basis for the structure and calibration of our model [63]. Because
the experimental data was formatted as force versus strain (ε), the modular spring coefficient
is also a function of strain, where strain is defined as Equation 3.1,
ε =
∆L
L0
(3.1)
where ∆L is the total elongation of the intra-fibrin spring length and L0 is the equilibrium
intra-fibrin spring length. To capture the strain-hardening phenomena in our model, we have
incorporated a modular spring coefficient, of Hill-type functional form, into the calculation
for the force resulting from the spring between two adjacent particles within a single fibrin
strand.
F (t) = F (t− 1) + k(ε)∆x+ ζccv (3.2)
k(ε) = k0 +
kmax × (ε)n
εMn + (ε)n
(3.3)
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The modular spring coefficient, k as defined in Equation 3.3, is a sigmoidal function of the
strain of the spring. The k0 term is the minimum spring coefficient measured at zero strain.
kmax defines the maximum spring coefficient measured at large strains. εM corresponds to
the strain at which half maximal force is achieved, and n, the Hill coefficient, determines
the rate by which the spring coefficient changes. Equation 3.2 describes the incremental
force resulting from the spring that is resolved at each time step by adding the product of
the spring coefficient and the displacement (k(ε)∆x) to the force at the previous time-step
(F (t− 1)).
Simple harmonic motion results when there is a restoring force proportional to the dis-
placement, so the third term on the right hand side of Equation 3.2, ζccv, incorporates the
dashpot that accounts for the dampened oscillations that are observed in vitro. In the third
term, v is the velocity of the spring elongation and ζ is the damping ratio defined as Equation
3.4,
ζ =
c
cc
(3.4)
where c is the actual damping coefficient and cc is the critical damping coefficient. The critical
damping coefficent, derived from Newton’s second law, is equal to 2
√
m× k(ε), where m
is the intra-fibrin particle mass. The damping ratio can vary from undamped (ζ = 0),
underdamped (ζ < 1), critically damped (ζ = 1), and overdamped (ζ > 1). Assuming a
critically damped system, the magnitude of the actual damping coefficient was equal to that
of the critical damping coefficient, or 2
√
m× k(ε).
3.3 Results of Fibrin Simulations
3.3.1 Single Extension-Retraction Cycle
We used the extension portion of the force-strain data collected by Liu et al., digitized
and included in Figure 9, to heuristically fit the parameters of 3.3. The corresponding
modular spring coefficient is plotted versus strain in Figure 10.
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Figure 9: The experimental and simulated force required for a single fibrin strand to extend
approximately 225% strain before retracted to complete a single pull for the modular spring
coefficients corresponding to Figure 10. Experimental data was digitized from [63].
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Figure 10: Spring coefficient trajectories used in the attractive force calculation between
neighboring particles in a simulated fibrin bundle of three particles extended (red) to ap-
proximately 225% strain, prior to retracting (black) to complete a single pull.
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Table 3: Spring coefficient Hill function parameters corresponding to Figure 10 for the single
extension-retraction scenario of a fibrin strand.
Parameters k0 kmax εM n
(Units) (kg/s2) (kg/s2) (% strain) (unitless)
Extension 0.01 0.24 75 5
Retraction 0.0025 1.12 190 15
To capture the viscoelastic behavior of fibrin, observed on force-strain curves by the
presence of an area between the extension and retraction curves, the Hill function parameters
are modified upon retraction when the previous extension exceeds the elastic limit of fibrin
(50% strain). From the retraction portion of the curve collected by Liu et al., digitized and
included in Figure 9, we know that fibrin has a much higher elastic modulus immediately
upon retraction, justifying the increase in kmax upon retraction. The slope of the retraction
curve changes much faster upon retraction compared to extension, justifying an increase in
εM and n. Finally, the terminal slope of the retraction curve is less steep than the initial
slope of the extension portion, justifying a decrease in k0 upon retraction. The retraction
portion of the force-strain curve in Figure 9 was used to fit the parameters of 3.3 when the
spring is retracting. The in silico reproduction of the force-strain curve generated in [63]
for the constant velocity single extension-retraction case, shown in Figure 9, demonstrates
that our model is able to capture the mechanics of fibrin extensibility and strain-hardening
viscoelasticity when we simulate a fibrin bundle composed of 59 particles. We first calibrated
the system with a strand of three particles before lengthening the in silico fibrin strands to
contain anywhere from 20-200 particles per strand. Independent of the strand length, in
silico fibrin strands exhibit the same dynamics upon stretching that are observed with the
system used to generate Figures 9-12.
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3.3.2 Consecutive Extension-Retraction Cycles
Liu et al. also observed interesting single fibrin strand dynamics during an experiment
by extending and retracting the same strand consecutively, increasing the maximum strain
with each cycle from 45% to 85% to 125% [63]. With the same Hill-type functional form
of the spring coefficient between adjacent fibrin particles within a bundle, we aim to simu-
late consecutive extension-retraction cycles and observe similar dynamics. Using the same
parameter fits for the extension portion of each cycle obtained in Chapter 3.3.1, and fitting
the parameters of Equation 3.3 for the retraction portion of the individual cycles in the
consecutive extension-retraction case, we can capture the increased energy dissipation that
is observed upon consecutive extension-retraction cycles with increasing maximum strain.
Following the same justification described in Chapter 3.3.1, the retraction portions of the
experimental force-strain curves in Figure 11 were used to heuristically fit the parameters
of Equation 3.3 when the spring is retracting in the simulation. The spring coefficient ver-
sus strain curves for the three consecutive extension-retraction constant-velocity case are
included as Figure 12.
As in Chapter 3.3.1, we first calibrated the system using a strand composed of three
particles before extending the in silico fibrin strand to contain 59 particles. Noting the
departure of our simulation from the experimental data for each cycle of the consecutive
extension-retraction case, observed in Figure 11, we can both increase k0 and simultaneously
decrease kmax for the extension case. Increasing K0 alone would improve the model fit in the
low-strain elastic regime, but worsen the fit at larger strains. The steps in the Hill function
parameters of the retraction spring coefficient (kmax, εM , and k0), which result from fitting
the individual cycles independently, create inherent discontinuities that would be observed if
a simulated fibrin bundle were to be retracted between the strain ranges simulated in Figure
11. To eliminate the steps between the model parameters, general functional forms of kmax,
εM , and k0 with respect to the maximum strain of the bundle as means to create continuity
and promote model stability. In doing so, predictions of the behavior of fibrin strands that
are extended and retracted between and beyond the strain ranges reported experimentally
by [63] would be possible. Following the justification described in Chapter 3.3.1 and from an
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Figure 11: The experimental and simulated force required for a single fibrin strand to extend
to a maximum 45% strain on the first pull (left), 85% strain on the second pull (center),
and 125% strain on the third pull (right) for the modular spring coefficients corresponding
to Figure 12. Experimental data was digitized from [63].
Figure 12: Extension and retraction spring coefficient trajectories used in the attractive
force calculation between neighboring particles in a simulated fibrin bundle of three particles
extended to a maximum 45% strain on the first pull (left), 85% strain on the second pull
(center), and 125% strain on the third pull (right).
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Table 4: Spring coefficient Hill function parameters corresponding to Figure 10 for the
consecutive extensions-retractions scenario of a fibrin strand.
Parameters k0 kmax εM n
(Units) (kg/s2) (kg/s2) (% strain) (unitless)
Extend/1st Retract 0.01 0.24 75 5
2nd Retract 0.005 0.45 75 15
3rd Retract 0.0033 0.75 110 15
observation of the current fitted parameter values included in Table 4, k0 will be a decreasing
function of the maximum strain, while both kmax and εM will be increasing functions of the
maximum strain.
3.4 Summary
In Chapter 3, the unique mechanical properties of fibrin can be captured in silico by
modeling fibrin strands as chains of small particles linked together with implicit springs. The
springs behave according to Hooke’s Law with a variable spring coefficient that is mapped
to experimental data. The isolated fibrin strand in silico model is capable of capture the
high extensibility, strain-hardening, and viscoelastic behavior of in vitro fibrin.
The modular elastic modulus of fibrin at increased strains is evident by a nonlinear slope
on the extension portion of its stress-strain curve [63, 44]. Specifically, the slope of the
stress-strain curve increases in magnitude or steepness with increased strain. At low strains,
the slope, or elastic modulus is constant because stress is directly proportional to strain.
At large strains, the slope increases dramatically, exhibiting a phenomena known as strain-
hardening. Strain-hardening behavior is believed to result from the increased availability of
contact sites on fibrin at large strains and consequently enables clots and thrombi to stiffen
in scenarios with increased deformation that could otherwise induce clot breakdown [123].
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We calibrated the implicit spring force between neighboring particles of the same strand
to extension-retraction data from in vitro fibrin. The mechanical properties can be measured
from stress-strain curves obtained by applying a stress, or a force per unit area, to the
polymer and recording the resulting strain, or the stretch of the polymer normalized to its
initial length [123]. From in vitro extension-retraction studies of single fibrin bundles, the
distinct mechanical properties can be quantified. Specifically, the degree of strain-hardening
is observed by a comparison of the steeper slope at larger strains to the initial slope steepness
of stress-strain curves [63]. The viscoelastic behavior is evident by the departure between
the extension and retraction curves, where the area between the curves is proportional to
the energy dissipated [62].
The calibrated single in silico fibrin strand mechanics from Chapter 3 results in an
in silico DEM-based model that captures the extremely extensible, strain-hardening, and
viscoelastic behavior of individual fibrin bundles. The model from this chapter functions
not only as a stand-alone entity, but also as a building block for a multiscale model that
includes fibrin networks composed of hundreds to thousands of strands. The fibrin network
simulations are explored in Chapters 4 and 5.
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4.0 Ex Vivo Platelet Aggregate Formation
4.1 Background
The focus of Chapter 4 is the development of a model that incorporates fibrin networks
into the cell-scale adhesive mechanics model from Chapter2. The trans-scale gap is tra-
versed to study the emergent behavior of assemblies of platelets and fibrin. Specifically, we
investigated how variations in blood composition of key blood components lead to differ-
ent qualitative and quantitative descriptors and pathologies. We can define relationships
between the concentrations of blood coagulation contributors and corresponding aggregate
morphologies, void size distributions, and permeabilities.
Several other models have been developed in recent years that are also motivated by the
essential role of platelet adhesive interactions during coagulation. These studies have focused
on the aggregatory behavior of activated platelets under various hemodynamic conditions.
Pivkin et al. have developed a 3D model using Dissipative Particle Dynamics (DPD) that
captures the reduced accumulation of platelets in the presence of red blood cells [84]. Other
studies developed continuum platelet aggregation models, based on PDEs, by considering
only the fluid phase and tracking platelets concentrations [29, 120]. While the contribu-
tions of these platelet aggregation models are noteworthy in this space, the rules governing
the platelet attachment and activation stage are not validated by experimental work. Xu
et al. developed a 2D discrete model that combined the discrete Cellular Potts Model
(CPM) of platelet and blood cell aggregation with continuous partial differential equations
(PDEs) describing the hydrodynamics of blood flow and the kinetics of coagulation reac-
tions [127]. Despite the biological detail that was incorporated into the CPM hybrid model,
the morphologies of the resulting simulated clots were not aligned with their experimental
counterparts. Mody and King constructed a 3D platelet aggregation model, named Platelet
Adhesive Dynamics (PAD), which captures a growing thrombus by considering individual
receptor-ligand bonds under simple shear flow. Although the PAD model does not incorpo-
rate the effect of platelet activation, the model accounts for the non-sphericity of platelets,
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which is typically ignored in most coarse-grained models [69]. Mori et al. applied Voigt’s
model, a spring and dashpot pair, to capture the adhesive behavior between platelets and two
plasma proteins, vonWillebrand Factor (vWF) and Fibrinogen [74]. Though a simple model,
it provides mechanistic insight on thrombus formation and rupture. These researchers have
used different computational approaches to model platelet adhesion and aggregation, but
few have investigated the effect that component concentrations have on aggregate properties
[58, 105, 116].
Using a discrete element method (DEM)-based approach, the three-dimensional model
developed herein investigates the morphological and mechanistic differences of aggregates
formed from varied compositions of platelets and fibrin. We considered platelets to be solid
spheres and describe the adhesive platelet-platelet and platelet-fibrin bonds using implicit
springs. The adhesive interactions were first calibrated to experimental data from isolated
platelet experiments [56, 77] before the simulations were expanded to include hundreds to
thousands of platelets, aligned with the conditions at the core of a clot or thrombus.
We considered two general scenarios of fibrin incorporation in our model that we believe
provide a simple yet effective manner to identify the critical role that fibrin plays during
coagulation and the diverse effect it can have on resulting clot morphology. In both fibrin
scenarios, we varied the platelet concentration from roughly 0.8-32 percent solid by volume.
The simulation results allow us to observe and compare the aggregates as a function of fibrin
structure and platelet concentration. The spatial variation was quantified by calculating the
void size distribution within the aggregates and their corresponding permeabilities. This
model as a whole can provide insight on the mechanism of platelet aggregation and the
potential effect of pathologic fibrin on aggregate formation.
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4.2 Model Development
4.2.1 Platelet and Fibrin Aggregate Generation
To investigate the aggregatory behavior of activated platelet assemblies, we expanded
our simulations from isolated platelet-platelet and platelet-fibrin interactions at the cell-
scale to include hundreds to thousands of platelets within a 4.2e5 µm3 three-dimensional
periodic framework. The number of in silico platelets included in each simulation was
determined by the desired solid volume fraction of platelets, which ranged from 0.008-0.32
and assumed 2 µm-diameter spherical platelet particles. The set platelet range corresponds
to a platelet count that would be representative of the concentration present at a clot core
or platelet plug. To initiate the simulations, the platelets were randomly placed within the
3D simulation box by assigning their x, y, and z coordinates from a uniform distribution
and ensuring that no two particles overlapped. At runtime, the platelets were given a slow
random velocity to facilitate the particle collisions. Particle interactions resulted when any
pair of particle centers had three radii of separation. The additional halo of adhesive contact
allowed particles to spontaneously interact before their surfaces made physical contact, which
is aligned with a platelet’s ability to grab nearby platelets [15]. Each simulation was run to
a pseudo-steady state, defined by a 25 µs or longer plateau of the median interaction force
across all of the simulation contacts.
To execute the implicit handling of fibrin within the simulations, platelet-platelet in-
teractions simply behaved as platelet-fibrin interactions, aligned with the platelet-fibrin pa-
rameter values listed in Table 1 from Chapter 2 to define the magnitude of the piecewise
spring force from Equation 2.3. The initial conditions for the implicit fibrin scenario for four
different simulations with platelet concentrations ranging from 0.008-0.32 solid by volume
are included in Figure 13a. Each of the four concentrations was simulated in triplicate with
uniquely randomized initial particle positions and velocities.
To handle fibrin explicitly, fibrin was included as rigid and immobile cylinders of finite
length. The diameter assigned to the fibrin cylinders was an order of magnitude smaller
than the platelet particles, or 0.02 µm. The network of fibrin cylinders was generated prior
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(a) 
0.8% 8.0% 16.0% 32.0% 
(b) 
0.8% 8.0% 16.0% 32.0% 
Figure 13: Initial conditions of aggregates within a 75 µm x 75 µm x 75 µm simulation
framework for both the implicit (a) and explicit (b) inclusion of fibrin and 0.8%, 8.0%,
16.0%, and 32.0% platelets by volume. Platelets are represented as colored dots and explicit
fibrin as blue lines.
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to placing the in silico platelet particles into the system. Each fibrin cylinder was defined
by its two endpoints whose positions were assigned at random to one of the six faces of
the simulation box. Fibrin cylinders were added to the system until the solid fibrin volume
fraction reached 0.03. The random assignment of the fibrin endpoints created variability in
the overall organization of the aggregates between each simulation, which can be qualitatively
explained by differences in the quantity, orientation, and length of the fibrin cylinders. An
example of the background fibrin mesh is included in Figure 14 for the 4.2e5 µm3 system.
In the simulations with explicit fibrin, platelet-platelet and platelet-fibrin adhesive in-
teractions followed their respective spring force parameter values that are listed in Table 1
of Chapter 2. The initial conditions for the explicit fibrin scenario with 0.03 solid fibrin by
volume and 0.008-0.32 solid platelets by volume are included in Figure 13b. Each of the
four platelet concentration conditions was simulated in triplicate with uniquely randomized
initial platelet positions, platelet velocities, and fibrin cylinder positions.
4.2.2 Platelet Nearest Fibrin Neighbors Search
Because the simulations were executed with periodic boundary conditions and fibrin was
modeled as cylinders of finite length, an additional step in the traditional nearest neighbor
search was required to identify the potential fibrin cylinders that were interacting with
platelets located near the simulation boundaries. We developed an automated search method
that is summarized schematically in Figure 15 for the instance that a platelet is located in
the corner of the simulation framework.
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Figure 14: Example of the fibrin network made up of system-spanning cylinders with end-
points located at the system walls of a 75 µm x 75 µm x 75 µm framework. The fibrin
cylinders are represented as blue lines.
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Figure 15: Schematic of the search method used to detect the nearest fibrin neighbors to platelets (orange particle) located near
a vertex of a simulation unit cell with periodic boundaries. Nearest fibrin neighbors are first identified in the original unit cell
(I) before they are identified in the adjacent unidirectional unit cells (II), bidirectional cells (III), and lastly the diagonal unit
cell (IV).
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Table 5: The seven adjacent and “self” unit cells that correspond to the example scenario
from Figure 15 and are searched within for interacting fibrin cylinders. Each adjacent search
cell is named by the coordinate direction it is positioned with respect to the “self” or the
original unit cell. The search cells are assigned a one or zero if interactions are possible or
not with the platelet of interest.
Search Box self X Y Z X + Y X + Z Y + Z X + Y + Z
Yes/No 1 1 1 1 1 1 1 1
In general, when a platelet is located near a vertex, the method searches in the seven
neighboring simulation frames. Due to the periodicity of the simulations, the neighboring
frames are repetitions of the unit cell. If a platelet lies near an edge, the method searches
in three neighboring cells (two unidirectional and one bidirectional), and if a platelet is near
a face, just one (unidirectional) neighboring cell is searched. The adjacent unit cells to
be searched are assigned as true as shown in Table 5. To execute the actual search in a
given adjacent cell, the in silico platelet is effectively repositioned by adjusting its position
according to Table 6. The inclusion of this additional step to the nearest neighbors search
algorithm enables the aggregates to form system-spanning networks in the presence of high
platelet concentrations.
4.3 Results of Platelet Aggregate Simulations
4.3.1 Morphology and Porosity
The steady-state DEM results for the platelet aggregates formed from both the implicit
and explicit inclusion of fibrin are included as Figure 16. Qualitative morphological differ-
ences can be observed across fibrin inclusion scenarios and platelet concentrations. These
differences can be quantified and provide pathological implications. Particularly apparent
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Table 6: The adjustments to the in silico platelet position that are necessary for the corre-
sponding “self” or imaginary nearby search boxes to be searched, where Nx, Ny, and Nz
are the simulation sizes in the X, Y , and Z directions, respectively, if the values in Table 5
indicate true.
X Y Z
self 0 0 0
X ±Nx 0 0
Y 0 ±Ny 0
Z 0 0 ±Nz
X + Y ±Nx ±Ny 0
X + Z ±Nx 0 ±Nz
Y + Z 0 ±Ny ±Nz
X + Y + Z ±Nx ±Ny ±Nz
in the 8.0% and 16.0% solid platelets by volume cases shown in Figure 16a, the absence of
explicit fibrin enables the formation of large voids as platelets aggregate into separate iso-
lated clusters or network-like structures. The spatial arrangement of the aggregates formed
in the lowest (0.8%) and highest (32.0%) concentrations for both fibrin scenarios are very
similar from a qualitative perspective. In the low concentration regime, the initial platelet
positions are far apart, so little particle-particle adhesion occurs. In the high concentration
regime, independent of fibrin inclusion method, the higher packing fraction and resulting
close proximity of the platelets facilitates a higher frequency of adhesive interactions.
To quantify the spatial arrangement of the aggregates, the pore size distributions (PSDs)
were estimated by calculating the three-dimensional Delaunay Triangulations from the final
platelet positions using the delaunayTriangulation function in MATLAB as validated by
Zhang et al. [131]. The probability density functions (PDFs) of the PSDs and cumulative
PDFs of the PSDs that correspond to the aggregate results shown in Figure 16 are included
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(a) 
0.8% 8.0% 16.0% 32.0% 
(b) 
0.8% 8.0% 16.0% 32.0% 
Figure 16: Resulting aggregates within a 75 µm x 75 µm x 75 µm simulation framework
formed from implicit (a) and explicit (b) inclusion of fibrin and 0.8%, 8.0%, 16.0%, and
32.0% platelets by volume. Platelets are represented as colored dots and explicit fibrin as
blue lines.
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Figure 17: Probability density functions of pore size distributions (top) and cumulative
probability densities of pore size distributions (bottom) of platelets only within aggregates
formed from implicit and explicit consideration of fibrin in silico at 0.8%, 8.0%, 16.0%, and
32.0% platelets by volume.
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as Figure 17. The line color distinguishes the fibrin scenario (implicit versus explicit) and
the line style distinguishes the platelet concentrations. In Figure 17, the fibrin particles are
excluded from the PSD calculation for the explicit fibrin scenario, leaving only platelets to
be considered in the PSDs for both fibrin scenarios. Figure 17 summarizes the effect that fib-
rin structure has on platelet organization during aggregation. The PSD results recapitulate
the qualitative spatial arrangement observations. In general, as the platelet concentrations
increase and void volumes decrease, the distributions become increasingly right-skewed as
the platelet concentration increases, corresponding to a decrease in the dominant pore diam-
eter. The variance across the distributions decreases with increasing platelet concentration,
indicating that the maximum pore size decreases with increasing platelet concentration. In
the highest and lowest platelet concentrations considered, the PSDs for both fibrin scenarios
nearly overlap, indicating no spatial dependency of aggregate formation on fibrin length,
stiffness, or mobility when the platelet concentration is above 32.0% or below 0.8% by vol-
ume.
On the contrary, the PSDs for the 8.0% and 16.0% platelet concentration cases do show
a sensitivity to the fibrin scenario. As seen in Figure 17, the tails of the PSDs for these
concentrations in the implicit fibrin scenario extend further to the right than the respective
tails belonging to the explicit fibrin scenario. By modeling the fibrin implicitly, physical
fibrin in this scenario could be either extremely short or long and flexible, thereby providing
an environment that would facilitate the formation of large pores or void volumes during
platelet aggregation. The multimodal distributions associated with the implicit inclusion of
fibrin stem from the existence of the isolated aggregates. The smaller intra-aggregate pores
form the left-most peaks and the inter-aggregate pores form the broader secondary peaks.
Figure 18 is included to show the effect of stiff and immobile fibrin (green curves) on the
PSD within the aggregates. The red curves are the same across Figures 17 and 18. When
the fibrin particles are considered in the calculation of the aggregate PSDs, the largest pores
shrink to 2 µm in diameter, the size of a single platelet, which is 5x smaller than the pores
within the aggregates formed from the implicit fibrin scenario. The overlap of the four
green PSD curves indicates that the pores are largely governed by the fibrin structure and
have little sensitivity to platelet concentration. The aggregates formed from the explicit
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Figure 18: Probability density functions of pore size distributions (top) and cumulative
probability densities of pore size distributions (bottom) calculated from platelets only (red)
and platelets and fibrin (green) within aggregates formed from the explicit inclusion of fibrin
at 0.8%, 8.0%, 16.0%, and 32.0% platelets by volume.
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inclusion of fibrin lack the large voids that are observable in the implicit fibrin scenario
because the rigid and immobile fibrin cylinders provide a stiff scaffold that sterically hinders
the aggregating platelets. The distinguishable PSDs that evolve from the simulated platelet
aggregates identify the platelet gap sizes that regulate the transport of signaling factors and
control downstream clot integrity [105].
4.3.2 Permeability of Aggregates
Aggregate permeabilities were calculated by employing D3Q19 LBM simulations with
the Bhatnagar-Gross-Krook single relaxation time collision operator approximation, which
was explained in Chapter 1.4.2.
Cylindrical solid boundaries were defined around the aggregates generated from the DEM
simulations and a periodic boundary was defined in the direction of the cylinder length.
The interface of a fluid-solid boundary was handled as a no-slip boundary by implementing
bounce-back (reflected) velocities. To minimize error in the permeability measurements, the
radius of the cylinder boundary was ten nodes less than the length of the DEM samples.
This ensured that the aggregates spanned the radius of the cylindrical opening and that no
gaps existed between the aggregates and the walls, aside from the expected voids within the
aggregates. Poiseuille flow, parallel to the length of the cylinder, was induced via a constant
pressure gradient boundary condition. In the direction of flow, additional fluid nodes were
added at both ends of the cylinder.
The platelet aggregates were coupled with LBM by assigning at least ten lattice nodes to
each platelet diameter. In the case of explicit fibrin inclusion, it was necessary to increase the
node to platelet resolution from ten to thirty lattice nodes in order to accommodate the order
of magnitude diameter differential that exists between platelets and fibrin. As a means to
increase the lattice resolution while maintaining a computationally feasible system, a smaller
sample with comparable solid volume fraction of platelets and fibrin was first extracted from
the larger platelet-fibrin aggregates. The samples extracted from the larger platelet-fibrin
aggregates were ten platelet diameters in length in order to eliminate the effect of media
length on permeability [121]. The fibrin cylinders from the DEM simulations were replaced
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0.8% 8.0% 
16.0% 32.0% 
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Z 
Figure 19: Cross-sections (X > 1
2
Xmax) of LBM solid nodes represented as filled voxels of
platelet-fibrin aggregate samples extracted from larger DEM-generated aggregates composed
of 0.8%, 8.0%, 16.0%, and 32.0% platelets (white) and 3.0% fibrin (blue) by volume within
a cylindrical solid boundary (red).
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with chains of adjacent spheres that were ten times smaller in diameter than the platelet
spheres. The corresponding aggregate samples can be visualized by filling the solid voxels
from the LBM simulations, as shown in Figure 19. The cylinder wall is red, platelets are
white, and fibrin is blue. Voxels with X > 1
2
Xmax are not shown in order for the interior of
the cylinder to be visible.
The permeability of porous media can be calculated with Darcy’s law, which is defined
as,
q = −k
µ
∇p (4.1)
where q is the interstitial flux, k is the permeability, µ is the dynamic viscosity of the
percolating fluid, and p is the pressure. In the constant pressure gradient boundary condition
scenario that we implement, any changes in permeability that results from changes in both
aggregate organization and void fraction are observed as changes in the measured fluid flux
at steady state. A pressure drop of 3e−10 Pa/m was chosen to ensure laminar flow and a
Mach number less than 0.1 so that compressibility of the fluid could be ignored.
The LBM simulation results are included in Figure 20 for the implicit (a) and explicit
(b) fibrin inclusion scenarios. The permeabilities of the DEM-generated platelet and fib-
rin aggregates that were calculated from LBM simulations are plotted in Figure 21, along
with experimental permeabilities of in vitro platelet and fibrin aggregates from literature
[125]. Consistent with the literature, the permeability of the simulated aggregates decreases
exponentially with increasing platelet concentration. The implicit and explicit inclusion of
fibrin in our model influenced the structural morphology and pore size distributions within
the emergent aggregates, which directly affected the aggregate permeabilities. The reduced
overall permeability that is observed in the case of explicit inclusion of fibrin when compared
to the implicit fibrin case is a result of both the lowered void volume and the small pore
sizes that are introduced by the presence of the fibrin particles.
For the LBM-derived permeabilities, the different rates of change of permeability with
respect to platelet concentration within the two classes of fibrin inclusion are correlated to the
sensitivity of the pore size distribution to changes in the platelet concentration. Exemplified
in Figure 17 by the distinguishable blue curves, the PSD of aggregates formed from implicit
fibrin are highly sensitive to the platelet concentration. Dissimilarly, the overlapping green
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(a)
(b)
0.8% 8.0% 16.0% 32.0%
Figure 20: X-Y cross sectional visualization of steady-state simulation results from LBM
simulations of flow through aggregates formed via implicit (a) and explicit (b) fibrin scenarios
at 0.8%, 8.0%, 16.0%, and 32.0% solid platelets by volume. Solid nodes are represented as
gray squares and fluid nodes as arrows in the direction of the flow with colors showing the
normalized magnitude of the flow velocity. The velocity field within each frame of this figure
was normalized independently.
61
0 5 10 15 20 25 30 35
% Platelets by Volume
10-4
10-2
100
102
A
bs
ol
ut
e 
Pe
rm
ea
bi
lit
y 
(
m
2 ) LBM Implicit FibrinLBM Explicit Fibrin
Experimental
Figure 21: Absolute permeabilities of aggregates calculated from LBM simulations of flow
through aggregates formed via implicit and explicit fibrin scenarios and experimental per-
meabilities obtained from [125].
curves in Figure 18 indicate a lower sensitivity of PSD to platelet concentration. From
Figure 21, it is apparent that for the same increase in platelet concentration or decrease
in void fraction, the decrease in permeability of aggregates formed from the implicit fibrin
scenario is greater than the decrease in permeability for the explicit fibrin inclusion. The
reason for this is that in the implicit fibrin scenario, the mean pore size and the variance of
the distribution decreases with increasing platelet concentration, but for the explicit fibrin
scenario, the PSDs remain the same.
The departure of the experimental permeabilities from the simulated permeabilities is a
result of the assumed sphericity of platelets. In reality, platelets are soft and flexible. Upon
activation and during aggregation, the deformation of platelets enables their small volumes
to cover larger surface areas to impede blood loss and effectively reduce the aggregate perme-
abilities [77]. However, if platelet activation is compromised or a certain pathology induces
platelet hardening, the simulated results from our model propose that these pathologies
would result in leaky clots with weak or compromised coagulation capacity.
62
4.4 Summary
Through the development of a DEM-based model of platelet aggregation, we have in-
vestigated the influence of platelet concentration and fibrin inclusion on the emergent clot
morphologies. Grounding the platelet adhesive mechanics in isolated single platelet experi-
mental results from the literature, we first calibrated individual interactions before scaling-up
our simulations to capture aggregatory behavior. We manipulated the method of fibrin in-
corporation in our model to simulate two pathological scenarios. We handled fibrin implicitly
to identify the influence of extremely flexible and/or short fibrin bundles and explicitly to
investigate the effect of inflexible and immobile fibrin.
After simulating the formation of aggregates across the fibrin inclusion scenarios and
the desired platelet concentrations of 0.8-32.0% by volume, the morphological differences of
the emergent platelet plugs were quantified. We calculated the aggregate permeabilities by
executing LBM simulations of fluid flow through the resulting aggregates. Despite the de-
parture from experimental counterparts due to the assumed platelet sphericity, we identified
a greater sensitivity of the aggregate permeabilities to platelet concentration in the implicit
fibrin scenario. The increased sensitivity of the aggregate permeabilities in the case of im-
plicit fibrin can be explained from the underlying variability of the PSDs. Without stiff and
immobile fibrin, increasing in the platelet concentration decreases the mean and variance of
the corresponding PSDs. However, in the presence of stiff and immobile fibrin, the number
of pores decreases, but the PSDs are insensitive to an increase in platelet concentration.
The simulated fibrin scenarios herein create the bounds of expected platelet behavior
during aggregation. The results allow us to observe and compare aggregate formation as
a function of fibrin structure and platelet concentration. These findings have important
implications for mass transport during clot formation. This model as a whole provides
insight into the mechanism of platelet aggregation and the potential effect of pathological
fibrin on aggregate formation. Furthermore, it can be used to support the design of drug
delivery strategies to control the formation and lysis of blood clots.
63
5.0 Platelet and Fibrin Aggregate Dynamics
5.1 Background
The focus of Chapter 5 is the development of a model that translates the combined
platelet and fibrin adhesive mechanics from the previous chapter (Chapter 4) into a dy-
namic framework, as a means to study the sensitivity of platelet concentration and adhesive
capacity on overall aggregate strength. The first step toward a more dynamic framework
includes the implementation of the flexible and mobile fibrin model, calibrated in Chapter
3, into network-like fashion. Modeling the fibrin network as a rigid scaffold of immobile
rods, as implemented in Chapter 4, provided the foundation for the conversion to a flexible
and mobile network explained in this chapter. Using a discrete element method (DEM)-
based approach, the three-dimensional model developed herein investigates the mechanical
differences of aggregates formed from varied platelet concentrations and adhesive capacities.
Consistent throughout this thesis, we considered platelets and fibrin to be solid spheres and
describe the adhesive platelet-platelet and platelet-fibrin bonds using implicit springs. The
adhesive interactions were first calibrated to experimental data from isolated platelet exper-
iments [38, 53] before the simulations were expanded to include hundreds to thousands of
platelets and fibrin strands, aligned with the conditions at the core of a clot or thrombus.
To investigate the in silico platelet and fibrin aggregate dynamics, we used the model
from Chapter 4 to generate a pseudo-steady state arrangement of the aggregates at various
specified conditions. After replacing the stiff and rigid fibrin cylinders with flexible chains
of fibrin particles, we simulated a uni-axial stretching experiment by forcing the velocity of
the top wall of the simulation box in an upward direction. We tracked the force on the wall
that resisted the wall displacement as a metric for the aggregate strength. By executing a
fibrin-control scenario in the absence of platelets, we can compare the relative increase in
the magnitude of the resistance stress upon the addition of platelets to calculate the platelet
contribution to the aggregate strength.
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In vitro, the platelet component of clot strength can be inhibited with the application
of glycoprotein IIb/IIIa receptor antagonist [90]. The platelet component of clot strength is
measured in the clinic by comparing TEG tracings with and without the platelet adhesion
antagonist. The difference in the TEG tracings before and after the application of the
platelet adhesion antagonist is equated to the platelet component of clot strength, which is
then used to guide the transfusion of platelets in the treatment of coagulopathies [98]. We
can use platelet component metrics from in vitro samples, reported in Ranucci et al., to
calibrate the comparable in silico outcomes from the dynamic platelet and fibrin aggregate
simulations explored in this chapter [90].
5.2 Model Development
5.2.1 Initial Condition Generation
To investigate the dynamical and mechanical properties of the in silico-formed aggre-
gates of platelets and fibrin from Chapter 4, we monitored the response of a simulated
continuous uni-axial stretch on the system and tracked the force that resisted the aggregate
expansion. To generate the initial conditions for the aggregate extension studies, we exe-
cuted the same aggregate formation simulations with three-dimensional periodic boundary
conditions according to Chapter 4.2.1. The volume of the simulation framework was 5.6e3
µm3 with a length to width to height ratio of 3:3:5. The fibrin concentration was 3% and
the platelet concentrations ranged from 0.8 to 32% solid by volume. The network of fibrin
was held constant across the extension studies so as to eliminate the effect of fibrin organi-
zation and arrangement on the resistance stress measurements. The constant fibrin network
arrangement enabled the isolated effect of platelet concentration and activation level.
To capture the unique dynamics that fibrin exhibits upon stretching, the immobile fibrin
strands, modeled as rigid cylinders in Chapter 4, were replaced with chains of small particles
linked together with implicit springs as established in Chapter 3. The fibrin particles that
composed each fibrin strand were positioned equidistantly along the lines defined by two end
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points. The endpoints of the lines were assigned at random to the faces of the simulation
framework. Given the two endpoints, pa = (xa, ya, za) and pb = (xb, yb, zb), and the fibrin
equilibrium spring length, s0, the fibrin particles were added in the direction of pa to pb
according to Equations 5.1 and 5.2.
pn+1 = (1− u)× pn + u× pb, (5.1)
where u =
s0√
(xb − xn)2 + (yb − yn)2 + (zb − zn)2
(5.2)
Fibrin particles were added in sequence until the euclidean distance between the current fibrin
particle, pn+1, and the final, pb, was less than or equal to the equilibrium spring length. The
number of fibrin particles that filled each strand varied across the set of strands depending
on the length of the original fibrin line/cylinder. The adjacent fibrin particles within the
same strand were connected by implicit springs that behaved according to Equation 3.2,
where the modular spring coefficient was defined as Equation 3.3. The parameter values of
Equation 3.3 are listed in Table 3. A schematic of the resulting fibrin network with fibrin
strands composed of adjacent particles is shown in Figure 22A.
To capture the cross-linked nature of the in silico fibrin networks, we modified the initial
condition of the fibrin network by fusing fibrin strands that intersected. In practice, one of
the two most-overlapped particles from intersecting strands is removed and the remaining
particle becomes tethered to the two nearest neighbors of the particle that was removed. Fol-
lowing Figure 23IA, this means the two most-overlapped particles from intersecting Strands
1 and 2 are fibrin particle 4 from Strand 1 and fibrin particle 9 from Strand 2. In this case,
fibrin particle 9 from Strand 1 is removed and the particle indices from Strand 2 are adjusted
accordingly. Fibrin particle 4 (blue) from Strand 1 gains two spring neighbors, particles 8
and 9 (gold) from Strand 2, aligned with Figure 23IB. Multiple strands can be involved in a
single cross-linking site, similar to the schematic representation shown in Figure 23II. In this
case, the three most-overlapped particles from the three intersecting strands are determined
and the fibrin particles with the greater indices (9 and 15) are removed and the remaining
fibrin particle (4) is assigned four new spring neighbors (8, 9, 13, and 14). There is no limit
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A B
Figure 22: Schematic of the fibrin network used for simulations within Chapter 5 with fibrin
strands composed of adjacent green spheres in A and crosslinked particles highlighted as
larger black spheres and non-crosslinked particles as white spheres in B for the same fibrin
network. There are a total of 45,387 particles within this system.
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Figure 23: Three cases (I, II, and III) of fibrin strand overlap that were considered for cross-
linking within the larger fibrin network. Row A shows the original fibrin strands with all
fibrin particles included and row B shows cross-linked strands, where the particle highlighted
in blue gains the two gold neighbors that belonged to the particle that the blue replaced.
68
to the number of spring neighbors a given fibrin particle can have. A particular fibrin strand
can also intersect nearby strands at separate sites as shown schematically in Figure 23III.
In this case, the particle replacement and new spring neighbor assignments are determined
as they were in case I from Figure 23. The fibrin network used for the simulations within
this chapter is shown in Figure 22, where the cross-linked fibrin particles are highlighted in
part B by representing them as enlarged black spheres and the remaining fibrin particles as
smaller white spheres.
interacting pairs =
N × (N − 1)
2
(5.3)
interacting pairs =
P × (2×N − P − 1)
2
(5.4)
For simplification and computational feasibility purposes, we ignored the inter-strand
fibrin particle interactions, which reduces the possible fibrin interactions to the nearest-
neighbor interactions within a strand or intersecting strands and platelet-fibrin adhesive
interactions. As a result, the number of potential interactions that can occur is substantially
reduced, which increases the speed of the simulations. When the fibrin-fibrin interactions
are not considered, the number of possible interacting pairs reduces from Equation 5.4 to
Equation 5.3, where N is the number of total particles (platelets + fibrin) and P is the
number of platelets.
pair index = j − i+ i× (i+ 1)
2
(5.5)
pair index = i×N + j − i× (i+ 1)
2
− 1 (5.6)
Schematically, the reduced number of interactions can be visualized by eliminating the
fibrin-fibrin interactions from the lower right section of the grid of interaction indices shown
in Figure 24. The indices of the interaction pairs must then be adjusted to eliminate the
fibrin-fibrin interactions by filling the grid in a row-wise manner instead of column-wise. To
accommodate the change in the grid filling direction from vertical to horizontal, Equation
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Figure 24: Schematic of the interaction index grid for a test system composed of 10 particles,
including 3 platelets and 7 fibrin. The indices identifying the unique interaction pairs of A
are calculated with Equation 5.5 and the pair indices of B are calculated with Equation 5.6,
where in both cases i corresponds to the index of the particle along the row, j to the index
of the particle along the column, and N to the total number of particles.
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5.6 is used in place of Equation 5.5, where i and j correspond to the indices of the interacting
particles, i > j, and N is again the total number of particles (platelets + fibrin).
Fusing the sites where fibrin strands intersect fosters the network connectivity, even
in the absence of fibrin-fibrin interactions. The effective cross-linking allows any and all
perturbations to the system to be felt throughout the network in a computationally feasible
manner.
5.2.2 Aggregate Extension Simulation Setup
To implement a continuous uni-axial stretch of the platelet and fibrin aggregates, a layer
of particles parallel to the x-z plane and located at the bottom of the fibrin network was
colored red and frozen in place to ground the platelet and fibrin aggregate. A separate
layer of particles that was also parallel to the x-z plane, but located at the top of the fibrin
network, was colored yellow and given a positive velocity in the y-direction of approximately
0.74 m/s. A visualization of the fibrin network with colored layers to identify the wall
particles is included as Figure 25A. As the yellow band of particles moved in the positive
y-direction and effectively stretched the system, the resistance to the stretch was measured
by adding the force of the particle interactions at the wall interface. The simulations were
run until the displacement of the system was stretched a total distance of 4 µm.
Prior to implementing the bands of frozen particles, an alternative simulation setup for
the continuous system stretching was considered in which two additional layers of parti-
cles designated as wall particles were positioned around the aggregate. One layer was placed
above the aggregate to simulate the top wall with a forced velocity in the positive y-direction
and the second layer was placed beneath the aggregate to simulate the bottom wall that was
frozen in place to keep the aggregate grounded during the extension studies. A visualization
of the fibrin network with additional layers of particles to function the aggregate walls is
included as Figure 25B. The addition of non-biological particles to function as the system
walls introduced complexities that were eliminated by deeming portions of the aggregates
that were already present as wall layers. The unnecessary complexities included the prop-
erties of the particles themselves, which could have artificially altered the results away from
71
physiology. The biggest concern was how to handle the wall-aggregate interface because it
was somewhat artificial and would be challenging to calibrate. In the end, the principle is the
same with respect to including walls on the aggregate ends that are parallel to the direction
of the stretching motion, but the interactions with the wall are grounded in physiology and
either platelet-fibrin, platelet-platelet, or fibrin-fibrin interactions.
The thickness of the wall of the fibrin aggregate was varied to determine the minimum
wall thickness that maintained a reasonable degree of connectivity throughout the aggregate.
The range of explored thicknesses corresponded to the sizes of the particles included in the
simulations. The smallest wall thickness of 0.2 µm aligns with the in silico fibrin particle
diameter and 2.0 µm is the diameter of the in silico platelet particles. Two additional wall
thicknesses of 0.4 and 0.8 µm were also investigated. Schematics of the initial conditions of
the four cases of varied wall thickness are included as Figure 26.
As a metric of the aggregate connectivity, the number of contacts with the wall and
the force on the wall resisting aggregate extension were measured as a function of the wall
thickness for the four aforementioned wall thickness scenarios. The measurements were
taken at the endpoint of the simulations, defined as a displacement of the top wall equal
to 4 µm. The number of contacts with the wall and the corresponding force on the wall
increases with respect to the wall thickness, but at different rates. The secondary y-axis
for both plots included in Figure 27 shows the normalized ratio of remaining contacts and
remaining force on the wall relative to the thickest wall scenario of 2 µm for 27a and 27b,
respectively. When the wall thickness decreases from 2 µm to 0.8 µm, 14 contacts with
the wall are lost, or ∼90% of the contact points remain. However, the force resisting the
aggregate extension reduces by ∼40%, meaning that the interactions responsible for the 10%
increase in wall contacts when the wall thickness increases from 0.8 µm to 2.0 µm hold a
significant weight with respect to the aggregate connectivity that they facilitate. The shift
from a linear relationship with respect to contact and force reduction in the 0.2 µm to 0.8 µm
range to a nonlinear relationship in the 0.8 µm to 2.0 µm range justified using 2.0 µm-thick
walls for the simulations executed herein.
The initial positions of the platelets within the fibrin networks were taken from the
pseudo-steady state positions of the aggregate formation simulations explained in Chapter
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A B
Figure 25: Schematic of the fibrin network with two variations of wall particle inclusion. In
A, two layers of intra-network fibrin particles are designated as the walls. In B, two layers
of additional non-fibrin particles are incorporated to act as the walls. In both wall inclusion
scenarios, the top wall particles are colored yellow, the bottom wall particles are colored red,
and the non-wall fibrin particles are green. Yellow particles are assigned a velocity in the
positive y-direction (up) and red particles remain stationary to ground the aggregate during
the stretching simulations. For the simulations executed within this work, the wall inclusion
scenario from A was implemented.
73
0.2 µm 0.4 µm 0.8 µm 2.0 µm
Figure 26: Schematic of the initial condition of the fibrin network with four different wall
thicknesses increasing (from left to right) from 0.2 µm to 2.0 µm, where particles composing
the bottom wall are colored red, particles composing the top wall are colored yellow, and
non-wall fibrin particles are colored green. Moving from left to right, the thickness of the
walls correspond to 1x, 2x, 4x, and 10x the diameter of the in silico fibrin strands.
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Figure 27: Number of contacts vs wall thickness (left) and wall force vs wall thickness (right)
for four fibrin aggregate wall thickness scenarios, including 0.2, 0.4, 0.8, and 2.0 µm that
correspond to the schematics of the fibrin aggregates depicted in Figure 26. Measurements
were recorded when the top wall displacement reached 4 µm, corresponding to the maximum
point of extension. The secondary y-axis for both of the plots shows the normalized ratio
with respect to the value at 2.0 µm.
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Table 7: Number of platelet particles included in the in silico aggregates shown in Figure
28 for various platelet concentrations within a 5.6e3 µm3 simulation framework. Platelet
particles were assumed to be spherical with a diameter of 2 µm.
Volume % 0.8 8 16 32
Platelets (count) 6 55 110 220
4. The platelet activation level was tuned to simulate the effect of varied activation and
adhesive capacity on aggregate strength or resistance to stretching. The activation level was
incorporated as a discrete parameter to discriminate between non-/weakly-, partially-, and
fully-activated states. The three levels correspond to those observed experimentally in [77]
that were used to calibrate the platelet-platelet adhesive interactions in Chapter 2. The
platelet activation level was uniform across all platelets within a given run and held constant
throughout the duration of each simulation. The number of platelet particles included for
each of the four simulated concentration scenarios are listed in Table 7. The platelet counts
were calculated to satisfy the appropriate volume fraction by assuming platelets to be spher-
ical with a 2 µm diameter and the simulation framework to have a volume of 5.6e3 µm3.
Schematics of the initial platelet and fibrin particle positions for the five platelet concentra-
tion scenarios are included as Figure 28. Simulations were performed in triplicate for each
combination of activation level and platelet concentration condition and a single execution
of the fibrin only control, amounting to a total of 37 unique runs.
5.3 Results and Discussion of Aggregate Stretching Simulations
5.3.1 Effect of Varied Platelet Concentration
The force resisting the vertical displacement of the top wall (yellow particles) of the
platelet and fibrin aggregates shown in Figure 28 was tracked as a function of the distance
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0.0% 0.8% 8.0% 16.0% 32.0%
Figure 28: The initial conditions of the aggregates with 0-32% solid platelets (black particles)
by volume and 3% solid fibrin (green particles) by volume. The wall layers are colored in
yellow (top) and red (bottom) and the fibrin network structure is consistent across the
platelet concentration scenarios.
the aggregate was stretched. Schematics of the final condition of the aggregates after a
displacement of 4 µm are included in Figure 29. The green portions of the fibrin strands,
visible in Figure 29, exhibit bends and curves, demonstrating the successful implementa-
tion of flexible and mobile fibrin strands. The emergent fibrin network rearrangement upon
stretching is variable and depends on the platelet concentration and platelet positions within
the aggregates. In the absence of platelets, the fibrin networks tend to rearrange first at the
cross-linked sites, shown in Figure 22B, and the subsequent particle rearranging occurs in
worm-like fashion as the perturbations travel along isolated fibrin strands and eventually
throughout the fibrin network. Without any platelets present and in the low platelet con-
centration regime (0.8% platelets), the connectivity within the aggregates is not expected
to be complete, meaning that some fibrin strands, especially ones oriented parallel to the
simulation faces, are not connected to the rest of the aggregate and do not rearrange during
the simulation.
When platelets are present within the aggregates, the platelets attract nearby fibrin
strands and the network effectively collapses around the platelets to form tighter networks.
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0.0% 0.8% 8.0% 16.0% 32.0%
Figure 29: The final conditions of the aggregates from Figure 28 with 0-32% solid platelets
(black particles) by volume and 3% solid fibrin (green particles) by volume after a 4 µm
vertical displacement of the top wall. The wall layers are colored in yellow (top) and red
(bottom) and the fibrin network structure is consistent across the platelet concentration
scenarios.
This effect can be observed qualitatively in the three highest platelet concentration regimes,
specifically 8-32% platelets, where the aggregates display a slight hour glass shape after
a 4-µm stretch as seen in the three right-most schematics of Figure 29. The qualitative
simulation results are supported by the physiological role of platelets in coagulation; platelets
contribute to overall clot strength by binding and tightening nearby fibrin fibers via their
strong contraction and adhesive forces [56].
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The dynamics of the resistance stress on the ascending aggregate wall are reported in
Figure 30 as a function of displacement in µm for the mean of three trials with the corre-
sponding 95% confidence interval about the mean for platelet concentrations ranging from
0-32%. A new random initial condition of platelet positions was generated for each trial
while maintaining the same fibrin network and the platelet activation level was controlled as
fully-activated. The plot shows that the magnitude of the force that resists the stretching of
the aggregates generally increases as function of the top wall displacement or the extent of
stretching. The magnitude of the resistance stress also increases as a function of the platelet
concentration.
As the platelet concentration increases, the inclusion of more platelets increases the num-
ber of possible platelet-platelet and platelet-fibrin adhesive interactions, thereby increasing
the aggregate strength or the force required to stretch the aggregate. The complete sepa-
ration of the 95% confidence interval bands from 0.8 to 32% indicates that the resistance
stress mechanics are highly sensitive to platelet concentration. The exception to this is
the 0% platelets or the fibrin-only scenario and the 0.8% platelets, whose curves overlap
slightly along the 4-µm trajectory. Those overlapped wall-force curves result because the
0.8% platelet scenario is not dense enough with respect to the platelets to result in any
platelet-platelet interactions, hence not enhancing the connectivity throughout the aggre-
gate to distinguish the dynamics from the fibrin-only scenario.
The large initial decrease in the resistance stress is likely due to high local strain that
is imposed on the wall-aggregate interface when the wall first begins to move, which is then
relaxed as the force creeps through the rest of the aggregate network. The tracked force in
Figure 30 is the sum of all platelet-fibrin and intra-strand fibrin-fibrin interaction forces in
the positive y-direction (up). Aligned with Figure 29, these interactions include yellow fibrin
particles with black platelet particles (platelet-fibrin) and yellow fibrin particles with green
fibrin particles (intra-strand fibrin-fibrin). Yellow fibrin particles with either black platelets
or green fibrin were excluded from the wall force calculation because their misaligned position
from the yellow-green interface and forced velocity imposed an aphysiological condition on
the yellow platelets and caused an erroneous contribution to the wall-force metric.
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Figure 30: Mechanics of resistance stress in dyne/cm2 on top wall of simulated platelet
and fibrin aggregates as a function of displacement in µm. The mean of three trials with a
shaded 95% confidence interval band are plotted for the fully-activated platelet condition of
platelet concentrations ranging from 0-32% solid by volume and 3% solid fibrin. Schematics
in Figures 28 and 29 correspond to displacements of 0 and 4 µm, respectively.
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5.3.2 Effect of Platelet Activation Level
As a means to investigate the effect of platelet activation level on aggregate strength,
we varied the platelet activation level from non-weakly-activated, partially-activated, and
fully-activated as explained in Chapter 2 for the platelet-platelet adhesive interactions. For
each subplot of Figure 31, the dynamics of the resistance stress on the ascending aggregate
wall are reported as a function of displacement in µm for the mean of three trials with
the corresponding 95% confidence interval about the mean for each of the three activation
levels. The title of each subplot from Figure 31 corresponds to the platelet concentration of
the aggregates.
Within each subplot, the curves corresponding to the three levels of activation are nearly
indistinguishable, indicating that the resistance stress mechanics within the in silico aggre-
gates are insensitive to platelet activation or platelet function. Mechanistically, this can
be explained by the magnitude of the adhesive forces between the platelet-fibrin interac-
tions and the platelet-platelet interactions. Platelet-fibrin adhesive interactions are nearly
thirty times stronger than the strongest platelet-platelet interactions [56, 77]. The magni-
tude of the platelet-fibrin interactions was not adjusted with the platelet activation level as
it likely would be in vivo or in vitro. However, regardless of changes in the strength of the
platelet-platelet adhesive interactions as the activation level varies from fully-activated to
partially-activated to non-weakly-activated, the platelet-fibrin interactions remain dominant
and govern the overall resistance stress magnitude and dynamics.
Platelet function or activation level affects the degree of platelet aggregation and fibrin
accumulation [77]. Both physiological changes alter the formation phase of the platelet and
fibrin aggregates, which are steps in the coagulation cascade that occur prior to the stage
of coagulation where this model is relevant. The simulation results demonstrate that after
platelets form aggregates within a fibrin network, the degree of platelet activation or the
platelet functionality has no effect on the overall strength of the aggregate.
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Figure 31: Mechanics of resistance stress in dyne/cm2 on top wall of simulated platelet and
fibrin aggregates as a function of displacement in µm. The mean of three trials with a shaded
95% confidence interval band are plotted for three platelet activation scenarios including non-
/weakly-activated, partially-activated, and fully-activated within each subplot that is titled
with the platelet concentration in solid volume percent, ranging from 0.8-32%.
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5.3.3 Quantifying Platelet Contribution
The curves from the aggregate extension simulations with nonzero platelet concentrations
from Chapter 5.3.1 and 5.3.2 can be normalized with respect to the fibrin-only case to
generate a metric that is comparable to the clinical measurement known as the platelet
contribution or the platelet component of clot strength. By subtracting the output of the
in silico aggregate extension studies from the fibrin-only scenario from the output with
platelets, the effect of platelets can be isolated.
In the clinic, the platelet component of clot strength is calculated by comparing TEG
tracings before and after the application of glycoprotein IIb/IIIa receptor antagonist, which
inhibits platelet adhesion [90]. In the presence of the platelet inhibitor, the magnitude of the
pin amplitude from a TEG run is smaller, so the envelope of the pin tracing, or the TEG
output, lies beneath the envelope of the pin tracing from the uninhibited platelet scenario.
The area between the curves, or the difference in the TEG tracings before and after the
application of the platelet inhibitor is equated to the platelet component of clot strength,
which is then used to guide the transfusion of platelets in the treatment of coagulopathies
[98].
Similarly, the area between the output curves from simulated aggregate extension studies
with and without platelets can be calculated using Equation 5.7. The area between curves
is the difference in the area under the curves.
platelet contribution =
AUCplatelets + fibrin − AUCfibrin
AUCplatelets + fibrin
× 100% (5.7)
The in silico platelet contribution can be depicted schematically as the highlighted region
of Figure 32, which corresponds to the difference in the AUC from the platelet + fibrin
aggregate extension curve and the AUC from the fibrin-only aggregate extension curve.
Equation 5.7 was used to generate the platelet contribution of all of the simulated aggregates
from Chapter 5.3.1 and 5.3.2, where the fibrin-only curve was constant, but the platelets +
fibrin curve varied based upon the simulation conditions.
In Figure 33, the results of the platelet contribution calculation are plotted as a func-
tion of the platelet concentration for 36 in silico aggregate extension simulations. Each of
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Figure 32: Visualization of the platelet contribution to aggregate strength highlighted as
the area between fibrin-only and fibrin + platelets curves, corresponding to Equation 5.7.
This particular fibrin + platelet scenario corresponds to a 32% solid platelets by volume,
but the area between curves can be calculated across all simulated platelet concentrations
and platelet activation scenarios.
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the explored platelet concentration and platelet activation level scenarios was performed in
triplicate. The AUCs from each simulation were calculated using the trapz function in MAT-
LAB. The mean platelet contribution (%) are reported with corresponding 95% confidence
intervals. As expected from the results reported in Chapters 5.3.1 and 5.3.2, the platelet
contribution is highly sensitive to the platelet concentration, but insensitive to the platelet
activation status.
According to Harr et al., the component contributions of platelets and fibrin to the clot
strength are estimated to be 80% and 20%, respectively, for normal hemostasis [39]. The
ratio of the component contributions can be calculated from the clot elasticity or the clot
amplitude TEG output metric. Dependent upon the contribution method, the ratio varies
nonlinearly with respect to the platelet count because clot elasticity and strength do not have
a linear relationship [90]. Although the methodology for measuring platelet contribution to
clot strength is somewhat debated, the general 80%/20% rule tends to apply, however, careful
attention must be paid when using the platelet component for transfusion guidance [98].
The results from the in silico platelet and fibrin aggregate extension scenarios, reported
in Figure 33, produced platelet contributions beneath the 80% threshold for normal platelet
component, meaning that all of the explored in silico scenarios align with a thrombocytope-
nia diagnosis, or low platelet count pathology. Even though the quiescent platelet volume is
less than one percent of blood, the local platelet concentration after platelet activation and
aggregation is much higher [102]. The 32% solid platelets by volume was the upper bound
of feasible in silico platelet concentrations due to the assumed rigid spherical structure and
the manner in which the initial condition was generated; By establishing the fibrin network
prior to placing the platelets within the simulation framework, the number of possible platelet
particle positions are restricted due to the steric hindrance that the fibrin network imposes.
However, despite not fully capturing the breadth of physiological platelet concentrations,
the model developed herein successfully captures the sensitivity of platelet contribution to
aggregate strength with respect to the platelet concentration.
The insensitivity of platelet contribution with respect to the platelet activation level or
platelet function observed from the in silico aggregate extension studies corroborates with in
vitro studies [90]. Platelet function and platelet count are known to be highly coupled, so it
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Figure 33: The mean platelet contribution to aggregate strength of three trials and corre-
sponding 95% confidence intervals about the mean plotted as a function of platelet concen-
tration ranging from 0.8-32% solid by volume for three platelet activation scenarios, including
non-weakly-activated, partially-activated, and fully-activated.
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is challenging both experimentally and computationally to isolate the two. In vivo, platelet
function influences all stages of the coagulation cascade, including the degree of platelet
aggregation and fibrin accumulation, which occurs upstream from the scope of the scenarios
modeled herein [77]. By focusing on the stage of coagulation after fibrin accumulation and
platelet aggregation, alterations in the platelet functionality may not manifest in silico to
the extent that they might in vivo.
5.4 Summary
Through the development of a DEM-based model of platelet and fibrin aggregate dynam-
ics, we have investigated the influence of platelet concentration and platelet activation level
on the contribution of platelets to the strength of in silico aggregates. By first expanding
the in silico platelet aggregation model from Chapter 4 to include flexible and mobile fibrin
strands, the model developed herein can be used to simulate platelet and fibrin aggregate ex-
tension scenarios. By grounding the platelet and fibrin adhesive mechanics and fibrin strand
extension mechanics in isolated experimental results from the literature, we have a calibrated
model appropriate for scaling-up our simulations to capture the dynamics of platelet and
fibrin aggregates.
The scale-up method for translating fibrin strands from rigid lines to chains of adjacent
particles connected by implicit springs in series was developed in a general manner that
can accommodate changes in fibrin strand length and individual fibrin particle sizes. The
crosslinking capacity of fibrin networks was also incorporated into the model development
through the design of an algorithm that considers the points of intersecting strands and ef-
fectively fuses overlapping particles through a remove-replace-reconnect sequence explained
in Chapter 5.2.1. Fusing the intersecting fibrin particles captures the fibrin network connec-
tivity, which enables the network extension simulations to exhibit the emergent behavior of
fibrin assemblies.
The influence of platelet concentration, in the range of 0.8-32% solid platelets by volume,
on the overall aggregate strength can be studied by modifying the number of platelet particles
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included in the simulation framework. The in silico aggregate extension studies show that
increasing the platelet concentration also increases the strength of the aggregates, which
was measured by tracking the force that resisted a uni-axial stretching motion. The platelet
activation level was also modified with the in silico aggregates, but no significant effect was
observed on the resulting aggregate strength with respect to the activation level changes.
We calculated the platelet contribution to the strength of the aggregates by comparing the
force versus distance curves for each platelet concentration and activation level scenario
combination to the force versus distance curve of the lone fibrin network. The resulting
range of platelet contribution values falls beneath hemostatic thresholds, identifying that
the simulated range of platelet concentrations correspond to a thrombocytopenia pathology.
Despite the small breadth of simulated platelet concentrations due to the assumed platelet
sphericity, the model can still capture the effect of platelet concentration on the platelet
contribution to aggregate strength that is observed clinically.
The model developed herein combined an independent platelet and fibrin adhesive me-
chanics model with another independent model of extensible fibrin to yield a model with the
capacity to model platelet and fibrin aggregate dynamics. The resulting model is grounded
in experimental isolated platelet adhesion studies and fibrin extension studies that serve to
calibrate the independent contributions. Together, this model as a whole provides insight
into the mechanism of platelet and fibrin aggregate dynamics. Furthermore, the resulting
model bridges the gap to the macroscale by approximating comparable metrics, like the
platelet contribution to clot strength, to those obtained from whole-blood assays.
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6.0 Summary and Outlook
6.1 Model Utility
6.1.1 Platelet Adhesive Mechanics
In Chapter 2, a DEM-based platelet adhesive mechanics model was developed that cap-
tures the phenomenological behavior of platelet-platelet and platelet-fibrin adhesion. The
cell-scale model serves as the foundation for the development of a multiscale model of co-
agulation by including the micro-mechanical contributions that influence downstream clot
formation. The platelet adhesion model is suitable to simulate the collective and emergent
behavior of platelet and fibrin interactions.
Within the platelet adhesive mechanics model, the platelet activation level is modifi-
able to accommodate four levels that govern platelet-platelet interactions. The levels range
from inactive (no adhesion) to fully-active (strongest adhesion). Both platelet-platelet and
platelet-fibrin adhesion is incorporated via implicit springs that are mathematically defined
as piecewise linear functions. The piecewise linear functions that describe the adhesive in-
teractions were calibrated to experimental data from the literature [77, 56]. With the aim
of utilizing the developed cell-scale model as the foundation of a larger, multiscale model,
the phenomenological nature of the model provides the computational feasibility required
for scale-up.
6.1.2 Fibrin Extensibility Mechanics
In Chapter 3, the unique mechanical properties of fibrin were modeled in silico by sim-
ulating fibrin strands as chains of small particles linked together with implicit springs. The
springs behave according to Hooke’s Law with a variable spring coefficient that is mapped to
experimental data. The isolated fibrin strand in silico model captures the high extensibility,
strain-hardening, and viscoelastic behavior of in vitro fibrin.
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We calibrated the implicit spring force between neighboring particles of the same strand
to extension-retraction data from in vitro fibrin studies [63]. The mechanical properties can
be measured from stress-strain curves obtained by applying a stress, or a force per unit area,
and recording the resulting strain, or the stretch normalized to its initial length [123]. The
model from this chapter functions not only as a stand-alone entity, but also as a building
block for a multiscale model that includes fibrin networks composed of hundreds to thousands
of strands.
6.1.3 Platelet and Fibrin Aggregate Mechanics
In Chapter 4, a DEM-based model of platelet aggregation was developed by scaling-
up the platelet adhesive mechanics model from Chapter 2 to include hundreds of activated
platelets. It was used to investigate the influence of platelet concentration and fibrin inclusion
on the emergent collective behavior and subsequent clot morphologies. We manipulated the
method of fibrin incorporation in our model to simulate two pathological scenarios. We
handled fibrin implicitly to identify the influence of extremely flexible and/or short fibrin
bundles and explicitly to investigate the effect of inflexible and immobile fibrin.
We characterized the morphological differences of the emergent in silico platelet and
fibrin plugs. We calculated the aggregate permeabilities by executing LBM simulations
of fluid flow through the resulting aggregates. Despite the departure from experimental
counterparts due to the assumed platelet sphericity, we identified the role that fibrin plays
in the flow through the aggregates. The stiff and immobile implementation of in silico fibrin
restricted the mobility of the platelets and also the pore size, thus limited the aggregate
permeabilities. The results from the simulated fibrin scenarios created the bounds of expected
platelet behavior during aggregation and enabled a comparison of aggregate formation as
a function of fibrin structure and platelet concentration. This model as a whole provides
insight into the mechanism of platelet aggregation and the potential effect of pathological
fibrin on aggregate formation.
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6.1.4 Platelet and Fibrin Aggregate Dynamics
In Chapter 5, the platelet and fibrin mechanical model was translated into a dynamic
framework to investigate the influence of platelet concentration and platelet activation level
on the contribution of platelets to the strength of in silico aggregates. By first expanding
the in silico platelet aggregation model from Chapter 4 to include flexible and mobile fibrin
strands, the resulting model can be used to simulate platelet and fibrin aggregate extension
scenarios. By grounding the platelet and fibrin adhesive mechanics and fibrin strand exten-
sion mechanics in isolated experimental results from the literature, we calibrated the model
components separately, prior to combining them to capture the dynamics of platelet and
fibrin aggregates.
We used the static fibrin network model as the scaffold for converting the rigid fibrin
cylinders to chains of adjacent particles connected by implicit springs in series. The known
geometry of the scaffold framework facilitated the crosslinking algorithm development within
the fibrin networks. The resulting crosslinked/fused particle locations provided the fibrin
network connectivity, allowing the network extension simulations to exhibit the emergent
behavior of fibrin assemblies.
The influence of platelet concentration on the overall aggregate strength was studied
by modifying the number of platelet particles included in the simulation framework. We
developed a method to calculate the platelet contribution to the strength of the aggregates
by comparing the force versus distance curves for each platelet concentration and activation
level scenario combination to the force versus distance curve of the lone fibrin network.
The resulting model provides insight into the mechanism of platelet and fibrin aggregate
dynamics and bridges the gap to the macroscale by approximating comparable metrics, like
the platelet contribution to clot strength, to those obtained from whole-blood assays. By
taking a bottom-up approach to the problem, the trans-scale relationships among the model
components were elucidated through the emergent behavior of the combined models. The
model functions as a general tool that can be expanded and used to predict the effects that
changes in blood composition have on hemostasis.
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The in silico aggregate extension studies performed herein were executed on a local server
and each run required several weeks to generate the included results. Because the acceleration
of the particles within these systems is possibly small, a quasi-static assumption could be
considered, which is appropriate for modeling slow deformations of granular materials [110].
In the case of very dense materials, the quasi-static assumption means that the normal force
calculations can be replaced with constants to drastically reduce the computational cost
of the simulations. However, if the assembly is loose and the particle impacts cannot be
ignored, the force terms must evolve according to classical DEM.
6.2 Future Work
The model that stands as the culmination of the work from this dissertation provides
the foundation for a general model that can be tailored toward a specific application or
expanded to include more functional detail. Including the influence of fluid blood plasma
is a logical consideration that can be explored through coupled LBM-DEM simulations of
platelet aggregation under flow. Results from studies of platelet aggregation under flow can
be used to inform the initial conditions of the platelet and fibrin aggregate studies from
Chapter 5, in place of the existing assumptions regarding initial platelet concentrations. It
is known that platelet activation levels influence the rate and capacity of platelet aggregation
and the ultimate packing density of platelet plugs in vitro [66]. The varied platelet activation
model developed in Chapter 2 can be coupled with a model of platelet aggregation under
flow as an avenue to explore this effect.
We can simulate platelet aggregation under a couette flow scenario to approach the
inclusion of an additional plasma component and to study the effect of platelet activation
level on aggregation. The model can be calibrated with a comparable experimental study that
measured the contractile forces in platelet aggregates within a microfluidic device [104]. In
vitro, the activation capacity of platelets was controlled by modifying the shear rate and the
concentration of inhibitory agents. Ting et al. designed a microfluidic system that contained
an array of fibrin-coated flow barriers that acted as the substrate for platelet aggregation. We
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can simulate the microfluidic array by including a single flow barrier set and implementing
periodic boundaries to execute repeated unit cells of the simulation framework. A schematic
of the unit cell of the described microfluidic array is included in Figure 34.
We can vary the platelet concentration as well as the platelet activation level at the
beginning of the LBM-DEM simulations and define a pressure drop across the x dimension
to initiate a constant flow rate in the direction of the flow. A schematic of the initial
condition with 40 platelets within the cross-sectional view is included as Figure 35. During
the simulations, the frequency of platelet adhesion and the force due to platelet contraction
can be tracked to investigate the sensitivity of those metrics to changes in the platelet count
and platelet function. A schematic of the steady-state flow scheme is included as Figure 36
where the fluid flows from left to right. The capture radius of the activated in silico platelets
can be tuned in order to fit the aggregation rate of the platelets to the data available in the
literature [104].
A fibrin polymerization model could also be developed that generates the strands and
networks that align with the model from Chapter 5. By incorporating fibrin polymerization,
the expanded model will be equipped to simulate platelet and fibrin aggregate formation
under flow. Such a model could be used to generate TEG tracings in silico. In modeling
the TEG in silico, specific relationships between the blood coagulation participants and
the measurable parameters of the TEG could be defined. A combined LBM-DEM in silico
model of an entire TEG would be unrealistic to simulate due to the computational expense
of calculating the interactions of the billions of blood cell particles across a time frame on
the order of minutes. Instead, we could model a volume fraction of a to-scale TEG as a unit
cell with periodic boundary conditions.
Through a dynamic in silico model of a TEG, the clot assembly and organization of the
blood particles could be visualized in real-time, which is not possible with existing TEGs
in the clinic. The organization of simulated clots could be paired with the TEG outputs to
establish certain patterns that result in specific TEG shapes. By recreating TEG tracings and
simulating various coagulopathic states, the model could also be used to explore and design
more precise treatments. It is possible and not unlikely that by incorporating the mechanistic
details into the cell-scale models, the computational framework could be used to identify
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Figure 34: Schematic of a three-dimensional 60 µm x 30 µm x 50 µm unit cell of the LBM-
DEM simulation framework with two solid, fibrin-coated flow barriers. Simulation boundary
conditions are periodic in x and z and fluid flows in the x-direction.
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Figure 35: Cross-section of initial condition of a three-dimensional LBM-DEM simulation
of the activation, aggregation, and adhesion of 40 platelets (in view) under flow with two
solid, fibrin-coated boundary walls impeding the flow. Simulation boundary conditions are
periodic in the x and z direction, and finite in y.
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Figure 36: Cross-section of fluid steady-state of a three-dimensional LBM-DEM simulation
of flow with two solid boundary walls impeding the flow. Simulation boundary conditions
are periodic in the x and z direction, and finite in y.
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several possible treatment designs. The model could then be used to determine patient
responses to treatments in silico, prior to administration in the clinic, so the traditional
heuristic cocktail of blood-product therapies given to patients with abnormal TEGs becomes
extinct.
The mechanistic cell-scale models of fibrin and platelets can be easily modified so as
to simulate coagulopathies. For instance, thrombocytopenia can be simulated by lowering
the platelet concentration; hemophilia would result in non-/weakly activated platelets; and
disfibrinogenemia, which is clinically defined as low fibrin functionality, can be simulated by
a decreased fibrin concentration. If hundreds of TEG shapes could be reproduced by varying
the initial blood composition as in Chapters 4 and 5, multiplicities in the readouts could be
sought to develop blood composition probability distributions for each TEG shape. More
precise treatments could be designed by observing the sensitivity of the blood composition
on the TEG shapes in response to changes in particular concentrations. From the hundreds
of simulated TEGs, subtle differences in TEG shapes could also be able to identified that
would indicate a strong benefit from a specific therapy. The model could be used to sim-
ulate enough TEGs with corresponding treatment trajectories to establish a database-type
reference for clinicians to use to inform treatment times and dosage regimens for patients
with coagulopathies as a means to improve their outcomes by moving the patient into an
acceptable clotting performance range.
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